Translate the website
Переведите этот вебсайт
Traduire ce site

CALL: (210) 442-8625

Request More Infomration










Scientific Publications

Dr. Gjumrakch Aliev and staff are continuously publishing scientific articles, book chapters, and books as well as delivering scientific presentations. Below is a list of publications. You can obtain more information about a specific publication by emailing us at

You can also see pubmed.gov here

JOURNAL ARTICLES & BOOK CHAPTERS:

Note: * Indicates Hot Paper.

A: Neuroscience and Alzheimer’s Disease Research Fields:

  1. Shi J., Perry G., Aliev G, Smith M.A., Ashe K.H, and Friedland R.P. Serum amyloid P is not present in amyloid ß deposits of a transgenic animal model. NeuroReport 10:3229-3232; 1999.
  2. Nunomura A, Perry G, Hirai K, Aliev G, Takeda A, Chiba S, Smith MA. Neuronal RNA oxidation in Alzheimer’s disease and Down's syndrome. Ann NY Acad. Sci 1999:893:362-364.
  3. Perry G., Nunomura A., Hirai K., Takeda A., Aliev G, and Smith M.A. Oxidative damage in Alzheimer’s disease; The metabolic dimension. Int. J. Dev. Neurosci. 2000, 1; 18(4-5):417-421.
  4. Perry G., Nunomura A, Friedlich A.L., Boswell M.V., Brazdil L, Jones P. K., Rottkamp C. A., Zhu X., Raina A.K., Hirai K., Friedland R.P., Shi J., Aliev G, Cash A., Russell R.L., Wataya T., Shimohama S., Atwood C.S., Smith M.A.. Factors Controlling Oxidative Damage in Alzheimer Disease: Metals and Mitochondria In: Free Radicals in Chemistry, Biology and Medicine (Eds: Yoshikawa T., Toyokuni S., Yamamoto Y and Natio Y). Chapter 45:2000.
  5. Perry G., Nunomura A., Jones P.K., Rottkamp C.A., Zhu X, Aliev G, Cash A., and Smith M.A. Oxidative imbalance is a major feature of Alzheimer disease. Current Topic in Biochemical Research, 2000, Vol.3, 151-156.
  6. Aliev G, Samedov S. KH., Seyidova D., LaManna J.C., Smith M.A., Perry G., and Gasimov E.K. The Pathogenesis of Cerebrovascular Lesions in AD. The Reports of the National Academy of Sciences of the Azerbaijan Republic, 2000, 4-6; 236-242.
  7. Aliev G, Smith M.A., Perry G., Seyidova D., Samedov S.KH., Friedland R.P., LaManna J.C., and Gasimov E.K. The Experimental Model of Alzheimer’s Disease and its selective pharmacological treatments. The Reports of the National Academy of Sciences of the Azerbaijan Republic, 2001, Vol. 57, No1-2; 112-118.
  8. Zhu X., Raina A.K., Rottkamp C.A., Aliev G, Perry G., Heather Boux H., and Smith M.A. Activation and redistribution of JNK/SAPK in degenerating neurons in Alzheimer Disease. J. Neurochemistry, 76:435-441, 2001.
  9. * *Aliev G,*Hirai K., Nunomura A., Russell R., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Cash A.D., Siedlak S.L., Harris P.L.R., Jones P.K., Peterson R.B., Perry G., and Smith M.A. Mitochondrial abnormalities in Alzheimer’s disease. The Journal of Neuroscience 2001:21(9):3017-3023. *Equal Contribution.
  10. Perry G, Nunomura A, Avila J., Perez M., Rottkamp C.A., Atwood C.S., Zhu X., Aliev G, Cash A., and Smith M.A. Oxidative Damage and Antioxidant Responses in Alzheimer’s Disease. In: Alzheimer’s Disease: Advances in Etiology, Pathogenesis and therapeutics. (Eds. Iqbal K., Sisodia S.S., & Winblad B.). 2001 John Wiley & Sons, Ltd. Chapter 34; 371-378.
  11. . *Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathology and Exper. Neurology. 2001 60(8):759-67.
  12. . Perry G, Nunomura A, Siedlak S.L., Harris P.L.R., Zhu X., Castellani R.J., Aliev G, and Smith MA. Oxidant and antioxidant responses in Alzheimer disease. Recent Research Development Biophys. Biochem. 2001 (1):35-41, ISBN; 81-7736-057-4.
  13. . **Aliev G, Smith M.A., Seyidova D., Neal M.V., Lamb B.T., Nunomura A., Gasimov E.K., Vinters H.V., Perry G., LaManna J.C., and Friedland R.P. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in AD. Brain Pathology, 2002 12(1) 21-35.
  14. . *Shi J., Perry G., Berridge M.S., Aliev G, Smith M. A., LaManna J. C., and Friedland R. P.. Labeling of cerebral amyloid ß deposits in vivo using nasally administrated basic fibroblast growth factor and serum amyloid P component. The Journal of Nuclear Medicine. 2002, 43(8):1044-1051.
  15. . *Perry G., Nunomura A., Cash A.D., Taddeo M.A., Hirai K., Aliev G, Avila J., Wataya T., Shimohama S., Atwood C.S., and Smith M.A. Reactive oxygen: its sources and significance in Alzheimer’s disease. J. Neural Transmission 2002, 62:69-75.
  16. . *Perry G, Nunomura A, Hirai K, Zhu X, Prez M, Avila J, Castellani RJ, Atwood CS, Aliev G, Sayre LM, Takeda A, Smith MA. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med. 2002 Dec 1; 33(11):1475-9.
  17. . * Aliev G, Seyidova D., Lamb B.T., Neal M.L., Siedlak S.L., Vinters H., LaManna J.C., Friedland R.P., Head E., Perry G., and Cotman C.W. Atherosclerotic lesions and Mitochondria DNA Deletions in Brain Microvessels as a Central Target for the Development of Human AD and AD-like Pathology in a Aged YAC AßPP transgenic mice. Ann. NY Acad. Sci., 2002 Vol. 977: 45-64.
  18. . Castellani R.J., Hirai K, Aliev G, Drew K.L., Nunomura A., Takeda A., Cash A.D., Obrenovich M.E., Perry G., Smith M.A. The role of mitochondrial dysfunction in Alzheimer disease. J. Neuroscience Research, 2002, 270(3):357-360.
  19. . Aliev, G. Is non-genetic Alzheimer’s disease a vascular disorder with neurodegenerative consequences? J. Alzheimer’s Disease, 2002, V.4 (6):513-516.
  20. . Aliev G, M.A. Smith and G. Perry. How long time we need to have to changes our mind that Alzheimer’s Disease is Mitochondrial Disease? http://www.alzforum.org/new/detail.asp?id=760
  21. . * Cash A. D., Aliev G, Siedlak S.L., H. Fujioka, H.V. Vinters, M. Tabaton, A.B. Johnson,. Paula-Barbosa M., J. Avila, P. K. Jones, M. A. Smith, G. Perry. Microtubule Reduction in Alzheimer Disease. Am. J. Pathol., 2003 162(5):1623-1627.
  22. . Aliev G Seyidova D., Raina A.K., Obrenovich M.E., Neal M.L., Siedlak S.L., Lamb B.T., Vinters H., LaManna J.C., Smith M.A., and Perry G. Vascular Hypoperfusion, Mitochondria Failure and Oxidative Stress in Alzheimer Disease. Proceeding Indian National Science Academy, 2003, B69 (2):209-238.
  23. Chao M., Zhu X., Raina A.K., Aliev G, Takeda A., Nunomura A., Tabaton, Perry G., and Smith M.A. Sources Contributing to the Initiation and Propagation of Oxidative Stress in Alzheimer Disease. Proceeding Indian Natl. Sci. Academy, 2003, B69 (2)251-260.
  24. . * Aliev G, Seyidova D., Lamb B.T., Obrenovich M., Neal M.L., Siedlak S.L., Vinters H., Smith M.A., LaManna J.C., and Perry G. Mitochondria and vascular lesions as a central target for the development of Alzheimer’s disease and Alzheimer’s disease-like pathology in transgenic mice. Neurol. Res., 2003, Vol. 25, 665-674.
  25. . Aliev G, Obrenovich M.E., Smith M.A. and Perry G. Hypoperfusion, Mitochondria Failure, Oxidative Stress and AD. J. Biomedicine Biotech, 2003, Vol. 3, 162-163.
  26. . * Aliev G, Smith M.A., Obrenovich M.E. and Perry G. Role of Vascular Hypoperfusion-Induced Oxidative Stress and Mitochondrial Failure in the Pathogenesis of Alzheimer Disease. Neurotoxicity Research, 2003 Vol. 5(6), 385-390.
  27. . *Lee HG, Petersen RB, Zhu X, Honda K, Aliev G, Smith MA, Perry G. Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? Brain Pathol. 2003 13(4): 630-8.
  28. . *Perry G, Nunomura A, Raina AK, Aliev G, Siedlak SL, Harris PL, Casadesus G, Petersen RB, Bligh-Glover W, Balraj E, Petot GJ, Smith MA. A metabolic basis for Alzheimer disease. Neurochem Res. 2003, 10:1549-52.
  29. . Aliev G, Smith M.A., de la Torre J., and Perry G. Atherosclerotic Lesions and Mitochondria DNA Deletions in Brain Microvessels as a Central target for the development of Human AD and AD-like Pathology in Aged Transgenic Mice. International Proceeding of the Third International Congress on VASCULAR DEMENTIA, October 23-26, 2003). MONDUZZI EDITORE, BOLOGNA, ITALY, V. ISBN 88- 323-3163-2, PP. 9-20.
  30. . Perry G., Raina A.K., Nunomura A., Lee H-G., Zhu X, Liu Q., Perez M., Cash A.D., Avila J., Castellani R.J., Atwood C.S., Aliev G, Takeda A. and Smith M.A. Oxidative Stress and the Pathogenic Mechanism of Alzheimer Disease. In: Alzheimer’s disease and Related Disorders: Research Advances (Eds., by K. Iqbal and B. Winblad). [Ana Aslan Intl. Acad. Of Aging, Bucharest, Romania] 2003, PP. 425-432.
  31. . Aliev G The role of mitochondrial abnormalities as a key target, not only as ATP producers through oxidative phosphorylation, but also as regulators of intracellular Ca2+ homeostasis and endogenous producers of ROS. In: Comments on Paper in Alzheimer Research Forum, 2 December, 2003.
  32. . Perry G., Avila J., Casadesus G., Nunomura A., Tabaton M., Cash A., Aliev G, Wataya T., Shimohama S., Drew K., Atwood C. and Smith M.A. The role of oxidative stress in the pathogenesis of Alzheimer’s disease. Rev Chil Neuro-Psiquiat, 2003; 41(Suppl 2): 47-52.
  33. . Cash A.D., Srinivas R., Rottkamp C.A., Zhu X., Taddeo M.A., Aliev G, Fujioka H., Atwood C.S., Sayre L.M., Castellani R.J., Smith M.A., and Perry G. Metal Homeostasis and its Relation to Oxidative Stress in Alzheimer’s disease. In: REDOX-GENOME INTERACTIONS IN HEALTH AND DISEASE, MARCEL DEKKER INC., 2003: 19, ISBN 0-8247-4048-3, PP. 425-437.
  34. . Vascular factors in Alzheimer’s disease: Alzheimer’ Research forum live discussion. J. Alzheimer’s Disease, 2004:673-681.
  35. . Casadesus G., Smith M.A., Zhu X., Cash A.D., Aliev G, Honda K., Peterson R.B., and Perry G. Alzheimer disease: Evidence for a central pathogenic role of iron-mediated reactive oxygen species. J. Alzheimer’s Disease, 2004, 6(2):165-169.
  36. . Moreira P.I., Nunomura A., Honda K. Liu Q., Aliev G, Oliveira C.R., Santos M.S., Zhu X., Smith M.A. and Perry G. Stress and Homeostatic Regulation of Oxidative Damage in Neurodegenerative Disease. In: XII Biennial Meeting of the Society for Free radical Research International SFRR (Buenos Aires, Argentina, May 5-9, 2004). Editors: S. Puntarulo and A. Boveris. Medimond International Proceeding. Volume ISBN, 2004; 88-7587-109-4, PP.219-224.
  37. . Aliev G, Moreira P.,  Oliveira C.,  Perry  G.,  Santos M.,  Smith M.A. Re: Lustbader JW, et al., ABAD directly links Aß to mitochondrial toxicity in AD. Science 2004; 304:448-452. In:http://www.alzforum.org/new/detail.asp?id=1000#{C8B04AEB-9CBE-4A9E-85BE-2B5579E8314B}.
  38. . * Aliyev A., Seyidova D., Rzayev N., Obrenovich M.E., Lamb B., A. Smith M., G. Perry, de la Torre J.C., and Aliev G Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer’s disease? Neurol. Res., 2004, V. 26 (5): 547-553.
  39. . *Seyidova D., Rzayev N., Aliyev A., Obrenovich M, Lamb B., A. Smith M., G. Perry, de la Torre J.C., Aliev G The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer’s disease. In Vivo, 2004, 18(3):325-334.
  40. . Dobrota D., Lyness S.A. and Aliev G Proceeding of the 11th International Symposium, “New Frontiers of Neurochemistry and Neurophysics on Diagnosis and Treatment of Neurological Diseases,” with Participation of the International Society for Neurochemistry (ISN), in Memory of Vincenzo Lombardi (Martin, Slovakia, December 4-7, 2003). J. Alzheimer’s Disease, 2004, V.6:547-568.
  41. . **de la Torre J.C., Aliev G and Perry G. Drug Therapy in Alzheimer’s disease (Letter to The Editor). New England Journal of Medicine, 2004, 351(18):1911-1913.
  42. . * Aliev G, Smith M.A. de la Torre J.C. and Perry G. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer’s disease. Mitochondrion, 2004; Vol 4/5-6:649-663.
  43. . * Zhu X., Smith M.A., Perry G. and Aliev G Mitochondrial failures in Alzheimer Disease. American J. Alz. Dis. and Other Dementia, 2004:19(6):345-352.
  44. . Moreira P.I., Siedlak S.L., Aliev G, Zhu X., Cash A.D., Smith M.A., Perry G. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. J. Neural Transm. 2005:112; 921-932. (Epub Head of Print: December 7, 2004).
  45. . Moreira P, Nunomura A, Petot GJ, Aliev G, Smith MA, Perry G: Brain metabolic alterations are early signs in Alzheimer disease pathophysiology, pp 61-65 (Vellas B: Nutrition, Cognitive Decline and Aging, Serdi Publisher, Paris), 2005.
  46. . **Bragin V., Chemodanova M. Dzhafarova N., Bragin I., Czerniawski J.L. and G. Aliev. Integrated Treatment Approach Improves Cognitive Function in Demented and Clinically Depressed Patients. Am. J. Alz. Dis. & Other Dementia, 2005; 20(1): 21-26.
  47. . Liu Q., Smith M.A., Avilá J., De Bernardis J., Kansal M., Takeda A., Zhu X., Nunomura A., Honda K., Moreira P.I., Oliveira C.R., Santos M.S., Shimohama S., Aliev G, de la Torre J., Ghanbari H.A., Siedlak S.L., Harris P. L.R., Sayre L.M. and Perry G. Alzheimer-Specific Epitopes of Tau Represent Lipid Peroxidation Induced Conformations. Free Radical Biol & Med, 2005, 15; 38(6):746-754.
  48. . Moreira PI, Smith MA, Zhu X, Honda K, Lee HG, Aliev G, Perry G. Oxidative damage and AD: Are antioxidant therapies useful? Drugs News Perspective, 2005, 18(1):13-19.
  49. . * Aliyev A., Chen S., Seyidova D., Smith M.A., de la Torre., and Aliev G Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer’s disease. J. Neurol. Science, 2005: V. 229-230; 285-292.
  50. . * de la Torre J.C. and Aliev G Inhibition of vascular Nitric Oxide after rat chronic brain ischemia: Spatial memory and immunocytochemical changes. J. Cerebral Blood Flow Metab. 2005:25(6):663-672.
  51. . Moreira P.I., Honda K., Liu Q, Aliev G, Oliveira C.R., Santos M.S., Zhu X., Smith M.A. and Perry G. AD Oxidative Stress: The Old Problem Remains Unsolved. Current Medicinal Chemistry - Central Nervous System Agents, 2005, 5(1):51-62.
  52. . Aliev G, Moreira P.,  Obrenovich M.E., Oliveira C.,   Smith M.A. and Perry  G. Comments: Re: Vijayvergiya C, Beal MF, Buck J, Manfredi G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci. 2005 Mar 9; 25(10):2463-70.
  53. . Aliev G, Moreira P, Obrenovich ME, Oliveira C, Perry G, Smith MA. Mitochondria: Another Dimension in Protein Misfolding (Comment), In: http://www.alzforum.org/pap/annotation.asp?powID=43769#{65E259F5-CF19-4976-B712-D910AF9C67F3}, 31 March 2005.
  54. . Moreira P.,  Honda K., Lee H., Santos M., Oliveria C.R., Aliev G, Nunomura A., Zhu X., Smith M.A., and Perry  G. Oxidative Stress: The old enemy in Alzheimer’s Disease Pathophysiology. Current Alzheimer’s Research, 2005; 2:403-408.
  55. . Moreira PI, Zhu X, Nunomura A, Honda K, Lee HG, Aliev G, Smith MA, Perry G. Oxidative stress in Alzheimer disease: an overview. Perspectives in Neurosciences in the Third Millennium: Baloyannis SJ, Ed. Greece Society for Amelioration of the Quality of Life for Chronic Neurologic Patients, Thessalonikh, Greece, 2005, pp. 419-433.
  56. . Zhu X, Perry G. Moreira PI, Aliev G, Cash A.D., Hirai K. and Smith MA, Mitochondrial abnormalities and oxidative imbalance in Alzheimer’s disease. J. Alzheimer’s Disease, 2006; 9:147-153.
  57. . * Obrenovich M.E., Smith MA., Siedlak SL., Chen S., de la Torre JC., Perry G. and Aliev G Overexpression of GRK2 in Alzheimer’s disease and in a Chronic Hypoperfusion Rodent Model is an Early Marker of Brain Mitochondrial Lesions. Neurotoxicity Res. 2006 10(1):43- P56.
  58. . Aliev G, Miller J.P., Leifer D.W., Obrenovich M.E., Shenk J.C., Smith M.A., LaManna J.C., Perry G., Lust W.D., and Cohen A.R. Ultrastructural analysis of a murine models of congenital hydrocephalus produced by overexpression of transforming growth factor-ß1 in the central nervous system. J. Submicr. Cytology & Pathol. 2006; 38(2-3)85-91.
  59. . Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A, Casadesus G, Harris PLR, Siedlak SL, Perry G. Vascular oxidative stress in Alzheimer disease. J Neurol Sci, 2007; 257:240-246.
  60. . Moreira PI, Siedlak SL, Santos MS, Oliveira CR, Fujioka H, Tabaton M, Nunomura A, Aliev G, Szweda LI, Zhu X, Smith MA, Perry G. Mitochondrial autophagocytosis in Alzheimer disease. In: Proceedings of the 10th International Conference on Alzheimer’s Disease and Related Disorders, Medimond S.R.l., Bologna, in Alzheimer’s Disease: New Advances, Iqbal K, Winblad B, Avila J, Eds, Medimond S.R.l., Bologna, Italy, 2006, pp 373-376.
  61. . Moreira P.I., Nunomura A., Honda K., Aliev G, Casadesus G., Zhu X., Smith M.A., and Perry G. The key role of oxidative stress in Alzheimer disease. In: "Oxidative Stress and Neurological Disorders." G.A. Qureshi, Parvez SH, Eds, Elsevier B.V., Amsterdam, 2007, pp 267-282.
  62. . *Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J. Neuropathology & Exper. Neurology, 2007, 66(6):525-532. Erratum in: J Neuropathol Exp Neurol. 2007 Jul; 66(7):674.
  63. . Aliev G, J. Liu, K. Xu, M. Puchowicz, S.L. Siedlak, J.C. Shenk, M.A. Smith, E. Gasimov, M.E. Obrenovich, K. Fischbach, J. Koistinaho, J.C. LaManna, B.N. Ames and Perry G. ApoE4 in mice induces age-dependent brain hypoperfusion, neuronal, glial and microvascular damage, and cognitive impairment, which can be prevented by feeding Acetyl-L-Carnitine and R-Lipoic Acid. Proceedings AD/PD Conference 2007. Monduzzi Editore, Bologna, Italy. 2007, H314C0563, PP.105-126.
  64. . *Moreira PI, Siedlak SL, Wang X., Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy. 2007 Nov-Dec; 3(6):614-5. Epub 2007 Aug 14.
  65. . * Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, Blum JS, Bredesen DE, Brodsky JL, Brumell JH, Brunk UT, Bursch W, Camougrand N, Cebollero E, Cecconi F, Chen Y, Chin LS, Choi A, Chu CT, Chung J, Clarke PG, Clark RS, Clarke SG, Clavé C, Cleveland JL, Codogno P, Colombo MI, Coto-Montes A, Cregg JM, Cuervo AM, Debnath J, Demarchi F, Dennis PB, Dennis PA, Deretic V, Devenish RJ, Di Sano F, Dice JF, Difiglia M, Dinesh-Kumar S, Distelhorst CW, Djavaheri-Mergny M, Dorsey FC, Dröge W, Dron M, Dunn WA Jr, Duszenko M, Eissa NT, Elazar Z, Esclatine A, Eskelinen EL, Fésüs L, Finley KD, Fuentes JM, Fueyo J, Fujisaki K, Galliot B, Gao FB, Gewirtz DA, Gibson SB, Gohla A, Goldberg AL, Gonzalez R, González-Estévez C, Gorski S, Gottlieb RA, Häussinger D, He YW, Heidenreich K, Hill JA, Høyer-Hansen M, Hu X, Huang WP, Iwasaki A, Jäättelä M, Jackson WT, Jiang X, Jin S, Johansen T, Jung JU, Kadowaki M, Kang C, Kelekar A, Kessel DH, Kiel JA, Kim HP, Kimchi A, Kinsella TJ, Kiselyov K, Kitamoto K, Knecht E, Komatsu M, Kominami E, Kondo S, Kovács AL, Kroemer G, Kuan CY, Kumar R, Kundu M, Landry J, Laporte M, Le W, Lei HY, Lenardo MJ, Levine B, Lieberman A, Lim KL, Lin FC, Liou W, Liu LF, Lopez-Berestein G, López-Otín C, Lu B, Macleod KF, Malorni W, Martinet W, Matsuoka K, Mautner J, Meijer AJ, Meléndez A, Michels P, Miotto G, Mistiaen WP, Mizushima N, Mograbi B, Monastyrska I, Moore MN, Moreira PI, Moriyasu Y, Motyl T, Münz C, Murphy LO, Naqvi NI, Neufeld TP, Nishino I, Nixon RA, Noda T, Nürnberg B, Ogawa M, Oleinick NL, Olsen LJ, Ozpolat B, Paglin S, Palmer GE, Papassideri I, Parkes M, Perlmutter DH, Perry G, Piacentini M, Pinkas-Kramarski R, Prescott M, Proikas-Cezanne T, Raben N, Rami A, Reggiori F, Rohrer B, Rubinsztein DC, Ryan KM, Sadoshima J, Sakagami H, Sakai Y, Sandri M, Sasakawa C, Sass M, Schneider C, Seglen PO, Seleverstov O, Settleman J, Shacka JJ, Shapiro IM, Sibirny A, Silva-Zacarin EC, Simon HU, Simone C, Simonsen A, Smith MA, Spanel-Borowski K, Srinivas V, Steeves M, Stenmark H, Stromhaug PE, Subauste CS, Sugimoto S, Sulzer D, Suzuki T, Swanson MS, Tabas I, Takeshita F, Talbot NJ, Tallóczy Z, Tanaka K, Tanaka K, Tanida I, Taylor GS, Taylor JP, Terman A, Tettamanti G, Thompson CB, Thumm M, Tolkovsky AM, Tooze SA, Truant R, Tumanovska LV, Uchiyama Y, Ueno T, Uzcátegui NL, van der Klei I, Vaquero EC, Vellai T, Vogel MW, Wang HG, Webster P, Wiley JW, Xi Z, Xiao G, Yahalom J, Yang JM, Yap G, Yin XM, Yoshimori T, Yu L, Yue Z, Yuzaki M, Zabirnyk O, Zheng X, Zhu X, Deter RL. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008, 4-2, 1-25. Epub 16 February, 2008. Autophagy. 2007 Nov 21; 4(2) [Epub ahead of print].
  66. . *Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, Smith MA, Perry G. Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med. 2008 Apr 15; 44(8):1493-505. Epub 2008 Jan 18.
  67. . *Aliev G, Gasimov E. Obrenovich M.E, Fischbach K., Shenk J.C., Smith M.A. and Perry G. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer’s disease. Vascular Health and Risk Management (VHRM), 2008:4(3), 721-730, Feb 21, 2008 [Epub ahead of print].
  68. . * Aliev G, Liu J, Shenk JC, Fischbach K, Pacheco GJ, Chen SG, Obrenovich ME, Ward WF, Richardson AG, Smith MA, Gasimov E, Perry G, Ames BN. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. Journal of Cellular and Molecular Medicine Volume13, Issue2, 2009.  320-333. Published Online: 29 Mar 2008. DOI 10.1111/j.1582-4934.2008.00324.x.
  69. . ***Aliev G, Shenk J.C., Fischbach K., and Perry G. Stem cell niches as clinical targets for anti-ischemic therapy. Nature Clinical Practice Cardiovascular Medicine. 2008, Vol 5, Sep; 5(9):590-1. Epub 2008 Jul 15.
  70. . Immunotherapy: Old Dogs, New Battle Comment by: Gjumrakch Aliev In: http://www.alzforum.org/pap/annotation.asp?powID=75944#{65D0D2D4-AFFE-4407-A914-E64E7CD71823}. Submitted 28 April 2008 .Posted 30 April 2008.
  71. . *Aliev G, Obrenovich M.E., Reddy V.P., Shenk J.C., Moreira PI , Nunomura A, Zhu X , Smith MA, Perry G. Antioxidant Therapy in Alzheimer Disease: Theory and Practice. Mini-Reviews in Medicinal Chemistry, 2008, Nov;8(13):1395-406.
  72. . * Aliev G, Cobb C., Pacheco G., Shenk J.C, Moreira PI, Fischbach K., Morales L.A., Gasimov E. and Perry G. The Role of Oxidative Stress and Vasoactive Substances in the Pathophysiology of Alzheimer’s Disease. In: BioMarkers for Early Diagnosis of Alzheimer's Disease, ISBN 978-1-60456-991-9 Editors: Daniela Galimberti and Elio Scarpini, 2008 Nova Science Publishers, Inc. Chapter IX, PP.241-265.
  73. . * Obrenovich ME, Morales LA, Cobb CJ, Shenk JC, Méndez GM, Fischbach K, Smith MA, Qasimov EK, Perry G. and Aliev G Insights Into Cerebrovascular Complications and Alzheimer Disease Through The Selective Loss of GRK2 Regulation. J. Cell. Mol. Med. Vol 13, No 5, 2009 pp. 853-865. [Epub ahead of print, 2008 Oct 6].
  74. . *Morales L.A., Pacheco G., Obrenovich M.E., Palacios H., Walrafen B. ,Qasimov E., LaManna J.C. and Aliev G Oxidative Stress-induced Mitochondrial Failure and Vasoactive Substances as Key initiators of Pathology Favor the Reclassification of Alzheimer Disease as a Vasocognopathy. NOVA: PUBLICATION CIENTÃFICA EN CIENCIAS BIOMÃDICAS –ISSN 1794-2470, VOL. 6, No10 JULIO-DICEMBRO DE 2008: 101-236. .Colombia 2009: 132-151. (Epub ahead print; DE 2008: 101-236).
  75. *Horecký J., Baciak L., Kašparová S., Pacheco G., Aliev G and Vancová O. Minimally Invasive Surgical Approach for Three -Vessel Occlusion as a Model of Vascular Dementia in the Rat– Brain Bioenergetics Assay. Journal of the Neurological Sciences 2009, v. 283 (1-2), 178-181 [Epub ahead of print, 2009 Mar 7].
  76. . *Shenk J.C., Liu J., Fischbach K., Xu K., Puchowicz M., Obrenovich M.E., Gasimov E., Alvarez L.M., Ames B.N., LaManna J.C. and Aliev G The effect of Acetyl—L-Carnitine and R-alpha-Lipoic Acid Treatment in ApoE4 mouse as a model for human Alzheimer’s disease. Journal of the Neurological Sciences 2009, v. 283 (1-2), 199–206 [Epub ahead of print 2009, Mar 31].
  77. . *Aliev G, Palacios H.H., Lipsitt A.E., Fischbach K., Lamb B.T., Obrenovich M.E., Morales L., Gasimov E, and Bragin V. Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotox. Res. 2009; 16:293–305 [Epub ahead of print 2009 May 30].
  78. . *Aliev G, Palacios H.H., Walrafen B., Lipsitt A.E., Obrenovich M.E. and Morales L.A. Brain Mitochondria as a Primary Target in the development of Treatment strategies for Alzheimer disease. International J. Biochemistry & Cell Biology, 2009; 41 1989–2004 [Epub ahead of print 2009, April 05], doi:10.1016/j.biocel.2009.03.015.   
  79. .  Moreira P.I., Nunomura A., Zhu X., Lee H.G.A.  Aliev G, Smith MA. and Perry G. Alzheimer Disease: Oxidative Stress and Compensatory Responses. In: Oxidative Neural Injury,  Contemporary Clinical Neuroscience, S.C. Veasey (ed.), Humana Press, a part of Springer Science Business Media, LLC 2009, PP. 109-120 [109.  DOI 10.1007/978-1-60327-342-8_7].
  80. .  *Aliev G, Palacios H., Aguirre A., Pacheco G.J., Gasimov E., Morales L., Gokhman D., Obrenovich M.E., Bragin V., Solis A. and Leszek J. Oxidative Stress Induced Mitochondrial Failure and Cellular Hypoperfusion: Implication in the Pathogenesis of Alzheimer Disease. Polish J. of Geriatric Psychiatry, 2009, vol. 6, No 4:155-179.
  81. . Gasimov E.K., Eyubova G.M., Aliev GM. Molecular basics of pathological changes in the vascular and glial elements of brain cortex during endotoxemia. Proceeding of the articles from the International Confreres dedicated to 90 years anniversary department of Human Anatomy of the Azerbaijan Medical University, Baku, 2009, p.172-175.
  82. . *Aliev G, Palacios H.H., Gasimov E., Obrenovich M.E., Morales L., Leszek J. Bragin V., Solís Herrera A. and Gokhman D. Oxidative stress induced mitochondrial failure and vascular hypoperfusion as a key initiator for the development of Alzheimer disease. Pharmaceuticals 2010, 3(1):158-187.
  83. . *Obrenovich M.E., Palacios H.H., Gasimov E., Leszek J and Aliev G The GRK2 overexpression as a primary hallmark of mitochondrial lesions during early Alzheimer disease. Cardiovasc Psychiatry Neurol. 2009;2009:327360. Epub 2010 Mar 3.
  84. . ****Aliev G, Palacios H, Gasimov E, Solis Herrera A, Leszek J, Gokhman D, Bragin V, Obrenovich M : Comment on Holmes et al hypothesis "Plaque removal is not enough to halt progressive neurodegeneration in Alzheimer Disease." In: http://hypothesis.alzforum.org/swan/browser/showEntity!showHypothesisRGraph1.action?objectId=urn%3Alsid%3Aswan.org%3Acomment%3Af078cafb-5e0e-4fa7-9d32-6da7ac314356
  85. . **Horecký J., Aliev G, Gvozdjáková A., Kucharská J. and Vancová O. Preventive and Therapeutic Coenzyme Q10 Supplementation In Rat Subjected to Cerebrovascular Ischemia-Reperfusion Injury. Current Neurobiology, 2010 1 (1): 30-36.
  86. . *Gasimov E.K., Guliyeva N.T. and Aliev GM. Morphological basis of the participation of arterioles in the formation of the acute endoneural edema. The Reports of the National Academy of Sciences of the Azerbaijan Republic, 2010 Vol. LXVI CILD (No1), 119-129.
  87. . *Vancová O., Baciak L., Kašparová S., Kucharská J., Palacios H.H., Horecký J. and Aliev G In vivo and in vitro assessment of brain bioenergetics in aging rats. J Cell Mol Med. 2010 Nov;14(11):2667-2674. doi: 10.1111/j.1582-4934.2009.00879.x.
  88. . **Obrenovich M.E., Nair G.N., Beyaz A, Aliev G and Reddy V.P. The Role of Polyphenolic Antioxidants in Health, Disease and Aging. Rejuvenation Research. December 2010, 13(6): 631-643. doi:10.1089/rej.2010.1043
  89. . **Aliev G and V.P. Reddy. Oxidative Stress-induced Cellular Hypoperfusion, Mitochondrial Failure and Brain Hypometabolism as the Causative Factors for the Pathophysiology of Cerebrovascular and Alzheimer Disease: Past, Present and Future 2010 ISSUE OF BenSci, A BENTHAM SCIENCE NEWSLETTER, ISSN: 1875-1898, 2010, vol.2 , 1-4.
  90. . Castellani R.J., Moreira P., Aliev G, Shenk J.C., Siedlak S.L., Harris P.L.R., Sayre L.M., Szweda P.A., Szweda L.I., Zhu X., Smith M.A. and Perry G. Hydroxynonenal-Generated Crosslinking Fluorophore And Mitochondria-Derived Lipoic Acid Accumulation In Alzheimer Disease Reveal A Dichotomy Of Protein Turnover. Microsc. Microanal. 16 (Suppl 2), 2010. 1014-1015. doi:10.1017/S1431927610059350.
  91. . *Aliev G Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. CNS & Neurological Disorders – Drug Targets, 2011 Mar;10(2):147-8.
  92. . **Palacios H.H., Yendluri B.B., Parvathaneni K. , Shadlinski V. B. , Obrenovich M. E., Leszek J., Gokhman D. , Gasiorowski K. Bragin V. and Aliev G Mitochondrion-Specific Antioxidants as Drug Treatments for Alzheimer Disease. CNS & Neurological Disorders – Drug Targets, 2011 Mar;10(2):149-62.
  93. . **Obrenovich M.E., Li Y., Parvathaneni K, Yendluri B.B., Palacios H.H., Leszek J. and Aliev G Antioxidants in health, disease and aging. CNS & Neurological Disorders – Drug Targets, 2011 Mar;10(2):192-207.
  94. . ** Gasiorowski K., E. Lamer-Zarawska, J. Leszek, K. Parvathaneni, B.B. Yendluri, Z. Blach-Olszewska and G. Aliev. Flavones from Root of Scutellaria Baicalensis Georgi: Drugs of the Future in Neurodegeneration? CNS & Neurological Disorders – Drug Targets, 2011 Mar;10(2):184-91.
  95. . *Ieradzki A., Yendluri B. B., Palacios H.H., Parvathaneni K. , Reddy V.P., Obrenovich M.E., Gasiorowski K., Leszek J. and Aliev G Implication of Oncogenic Factors as a Treatment Strategy for Neurodegenerative Disorders in the Context of Chronic and Potentially Terminal Diseases – Contemporary Approaches. CNS & Neurological Disorders – Drug Targets, 2011 Mar;10(2):175-83.
  96. . **Horecký J., Gvozdjáková A., Kucharská J., Obrenovich M.E., Yendluri B.B., Palacios H.H., Vancová O., and Aliev G Effects of Coenzyme Q and Creatine Supplementation on Brain Energy Metabolism in Rats Exposed to Chronic Cerebral Hypoperfusion. Current Alzheimer Res, 2011, 8, No 5 (in press). 2011 May 18. [Epub ahead of print]
  97. . *Aliev G, Palacios H., Obrenovich M.E. Gokhman D., Gasiorowski K., Leszek J. and Bragin V. Oxidative Stress Induced Vascular Hypoperfusion, Mitochondrial Failure Are Missing Links for the Development of Alzheimer Disease. In: Vascular Dementia, Editor: Sarah R. Jacobsen, ISBN: 978-1-61122-313-2, 2011 Nova Science Publishers, Inc. 2011, March. Chapter II (in press).
  98. . *Aliev G, Palacios H., Gokhman D., Gasiorowski K., Bragin V., Leszek J. and Obrenovich M.E. GRK2 Overexpression is a Primary Hallmark of Vascular Hypoperfusion and Mitochondrial Lesions During Early Alzheimer Disease: New Target for Drug Treatment? In: Vascular Dementia, Editor: Sarah R. Jacobsen, ISBN: 978-1-61122-313-2, 2011 Nova Science Publishers, Inc. 2011, March. Chapter III (in press).
  99. . *Aliev G, Palacios H., Betts B., Obrenovich M.E., Gasiorowski K., Gokhman D., Leszek J. and Bragin V. Mitochondrion Selective Antioxidants as Drug Treatments for Alzheimer Disease. In: Vascular Dementia, Editor: Sarah R. Jacobsen, ISBN: 978-1-61122-313-2, 2011 Nova Science Publishers, Inc. 2011, March. Chapter IV (in press).
  100. . **Palacios H.H., Obrenovich M.E., Gasiorowski K., Gokhman D., Bragin V., Leszek J. and Aliev G Alzheimer disease as a result of mitochondrial failure due to oxidative stress and cellular hypoperfusion: Missing Links? Polish Journal of Old Age Psychiatry, 2011, June (in press).
  101. . **Obrenovich M.E., Gasiorowski K., Palacios H.H. , Gokhman D., Shadlinski V.B., Bragin V., Leszek J. and Aliev G Selective loss of GRK2 regulation and its consequences: cerebrovascular complications and Alzheimer disease. Polish Journal of Old Age Psychiatry, 2011, September (in press).
  102. . **Aliev G, Palacios H.H., Obrenovich M.E., Bragin V., Gokhman D., Shadlinski V.B., Leszek J. and Gasiorowski K. Therapeutic Effects of Acetyl-L-Carnitine and Lipoic Acid in Aged Rats: Amelioration of Mitochondrial Damage in Neurons. Advances in Clinical and Experimental Medicine. 2011, June (in press).
  103. . **Aliev G The Role of oxidative stress, mitochondria failure and cellular hypoperfusion in the pathobiology of Alzheimer disease. Preface. 2011; 000-000 ISBN: 978-81-308-0367-8; Editors: Aliev G., et al., Publisher Research Signpost, Inc., 2011. PP.1-6.
  104. . *Leszek J. and Aliev G Vascular pathology in the pathogenesis of Alzheimer’s disease. In: The Role of oxidative stress, mitochondria failure and cellular hypoperfusion in the pathobiology of Alzheimer disease. 2011; 000-000 ISBN: 978-81-308-0367-8; Editors: Aliev G., et al., Publisher Research Signpost, Inc. 2011, Chapter 1, PP. 1-18.
  105. . * Palacios H.H., Solis Herrera A., Cobb C.J., Pacheco G.J., Fischbach K., Obrenovich M.E., Shadlinski V.B., LaManna J.C., Bragin V. and Aliev G Development and progression of Alzheimer disease as a result of cellular hypoperfusion from oxidative stress and mitochondria failure as primary pathogenic factors. In: The Role of oxidative stress, mitochondria failure and cellular hypoperfusion in the pathobiology of Alzheimer disease. 2011; 000-000 ISBN: 978-81-308-0367-8; Editors: Aliev G., et al., Publisher Research Signpost, Inc. 2011, Chapter 3, PP. 45-81.
  106. . *Obrenovich M.E., Solis Herrera A., Cobb C.J., Fischbach K., Shadlinski V.B. and Aliev G Lessons learned from the selective loss of GRK2 regulation and consequent cerebrovascular complications and Alzheimer disease . 2011; 000-000 ISBN: 978-81-308-0367-8; Editors: Aliev G., et al., Publisher Research Signpost, Inc. 2011, Chapter 9, PP. 203-226.
  107. . *Horecký J, Baciak L, Kašparová S, Pacheco G, Aliev G and Vancová O. Three-Vessel Occlusion: A surgical approach for Vascular dementia in the rat with low invasiveness can use design or technique. In: The Role of oxidative stress, mitochondria failure and cellular hypoperfusion in the pathobiology of Alzheimer’s disease. 2011; 000-000 ISBN: 978-81-308-0367-8; Editors: Aliev G., et al., Publisher Research Signpost, Inc. 2011, Chapter 10, PP. 227-236.
  108. . *Aliev G, Liu J., Fischbach K., Pacheco G.J., Palacios H., Walrafen B., Obrenovich M.E., Shadlinski V.B., Solis Herrera A., and Ames B. N. Feeding Acetyl-L-Carnitine and Lipoic Acid to Aged Rats Ameliorates Neuronal Mitochondria Damage. In: The Role of oxidative stress, mitochondria failure and cellular hypoperfusion in the pathobiology of Alzheimer disease. 2011; 000-000 ISBN: 978-81-308-0367-8; Editors: Aliev G., et al., Publisher Research Signpost, Inc. 2011, Chapter 13, PP. 273-296.
  109. . *Aliev G, Liu J., Fischbach K., Xu K., Puchowicz M., Obrenovich M.E., Shadlinski V.B., Solis Herrera A., Ames B.N. and LaManna J.C. The response to Lipoic acid and acetyl-L-Carnitine regiments in ApoE4 mice serves a model for Alzheimer Disease in humans. In: The Role of oxidative stress, mitochondria failure and cellular hypoperfusion in the pathobiology of Alzheimer’s disease. 2011; 000-000 ISBN: 978-81-308-0367-8; Editors: Aliev G., et al., Publisher Research Signpost, Inc. 2011, Chapter 14, PP. 297-316.
  110. . *Bragin V. and Aliev G Progression of Cognitive Function after Integrated Treatment Approach in Demented and Clinically Depressed Patients. In: The Role of oxidative stress, mitochondria failure and cellular hypoperfusion in the pathobiology of Alzheimer’s disease. 2011; 000-000 ISBN: 978-81-308-0367-8; Editors: Aliev G., et al., Publisher Research Signpost, Inc. 2011, Chapter 15, PP. 317-325.
  111. . **Aliev G, Palacios H.H., Obrenovich M.E., Bragin V., Gasiorowski K., Gokhman D. and Leszek J. Preventative effects of Lipoic acid and Acetyl-L-Carnitine in ApoE4 mice as a model for Alzheimer Disease in humans. International J Alzheimer’s Disease. 2011 (in press).
  112. . *Aliev, G. “Is Alzheimer Disease Vascular Disorders with Neurodegenerative Consequences: Past, Present and Future”. Monograph Book: Nova Science Publishers, Inc., New York, 2012 (in press).
  113. . * Aliev G, Li Y., Palacios H., and Obrenovich M.E. Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark for the Drug Development in the Context of the Cardiovascular Diseases: Past, Present and Future. Recent Patents on Cardiovascular Drug Discovery, 2011 (pending).
  114. . **Bragin V., Chemodanova M., Bragin I., Dzhafarova N., Mescher I., Chernyavskyy P., Obrenovich M.E., Palacios H.H. and Aliev G Long-Term Stability and Improved Cognitive Function in Dementia Accompanied by Depression: A 60-Month Follow-Up of a Naturalistic Study of Integrative Treatment for Real-Life Geriatric Patients with Multiple, Chronic Illnesses. Current Alzheimer Research, 2011 (revised pending).
  115. . Magalov S.I., Hasanov N.F., Azizova N.X., Novruzov A.N., Mustafayev Z.B., Kazimov S.A., Sultanov S.Sh., Hasanov E.N. and Aliev G A Population Study on the Prevalence of Epilepsy in the Nakhichevan Autonomous Republic of Azerbaijan. CNS & Neurological Disorders - Drug Targets. 2011 (submitted).
  116. . ** Gasiorowski K., Burnstock G. and Aliev G Nitric Oxide Dependent Mitochondrial Lesions in Human Multiforme Glioblastoma and Metastatic Colorectal Liver Cancer. J. Cellular and Molecular Medicine, 2011 (pending).
  117. . ***Aliev G, Palacios H., Obrenovich ME., Leszek J., Gasiorowski K., and LaManna J.C. Mitochondrial Abnormalities in Alzheimer Mice Brain is Associates with Atherosclerotic Changes in Brain Microvessels. J. Neuropathology and Experimental Neurology 2011 (pending).
  118. . Aliev  G., Manczak M., Grant K.A.  and P. H. Reddy.  Ultrastructural lesions of the mitochondria as a hallmark for liver and neuronal lesions during chronic ethanol self administration in Cynomolgus monkeys. J. Cellular and Molecular Medicine, 2011 (submitted).
B: Cardio- and Cerebrovascular Pathobiology, General Cell Biology, Cancer and other Research Fields:

  1. Aliev G Compensatory potency of arterial endothelium after ischemia and sudden death of an organism. In: Pogorelov Y.V. (Eds.,) "Compensatory Processes". Ivanovo, Russia, 1987:55-58.
  2. Rekhter M.D., Aliev G, Salapina O., Vyalov S., and Bauman O. Interactions of the vessel wall cells in early ontogenesis, injury and reparative regeneration. In: (Zegidashvili Y., Eds.) "Biology of the Cell". Tbilisi, Georgia, 1987; II: 874-876.
  3. Aliev G and Mironov A. Scanning electron microscopic analysis of rat aortic endothelium in different conditions after sudden death. In (Novikov I.I., Eds.,) "Urgent Surgery of Vessels". Yaroslavl, Russia, 1988: 126-129.
  4. Aliev G and Mironov A. The examination of the viability of aortic endothelium after ischemia and blood recirculation. In: "The Laboratory of Animal Sciences". Moscow Puchino, 1989:325-330.
  5. Aliev G and Mironov A. Structure of endothelium in the thoracic and abdominal parts of the intact rat aorta at various regimens of preparation and making specimens. Arkhiv Anatomy, Histology and Embryology, 1990; 99(12): 31-36.
  6. Aliev G and Mironov A. Ultrastructural features of abdominal aortic endothelium in different methods of prevention after the sudden death. Azer. Medical J., 1990; 5:8-17.
  7. Aliev G and Mironov A. Ultrastructural analysis of aortic endothelium after the sudden death. Arkhiv of Pathology, 1991; 53:30-35.
  8. Aliev G and Mironov A. The quantitative criteria of aortic EC viability after ischemia and blood recirculation. In (Kataev S.I., Eds.,) "Mechanisms Damaging of the Cell and Tissue". Ivanovo State University, Ivanovo, Russia, 1990: 20-24.
  9. Aliev G The Atlas of Scanning Electron Microscopy of Large Vessels Endothelium (IL Laboratorio Endotheliale In Imagini). SINAX S.P.A., Farmaceutici Gruppo FIDIA, Italy. 1991: 32 PP.
  10. Gassaniga P.P., and Aliev G Criteri di trattamento farmacologico delle condizioni di rischio trombotico. Neuroscienze e Invecchiamento Cerebrale, 1991; 2(6):46-53.
  11. Cirillo R., Aliev G, Italiano G., and Prosdocimi M. Functional responses of hindlimb circulation in aged normal and WHHL rabbits. Atherosclerosis, 1992; 93:133-144.
  12. Cirillo R., Salvatico E., Aliev G, and Prosdocimi M. Ischaemia and reperfusion of rabbit hindlimb: Evidence for a probably involvement of leukocytes in the reperfusion-mediated tissue and vascular injury. Journal of Cardiovascular Pharmacology, 1992; 20:969-975.
  13. * Aliev G, Cirillo R., Salvatico E., Paro M., and Prosdocimi M. Changes in vessel ultrastructure during ischaemia and reperfusion of rabbit hindlimb: Implications for therapeutical interventions. Microvascular Research, 1993; 46(1): 65-76.
  14. * Aliev G, Mironov A., Cirillo R., Mironov A. (Jr.), Gorelova E., and Prosdocimi M. Evidence for the presence of early atherosclerotic lesions in new-born WHHL rabbits. Atherosclerosis, 1993; 101: 17-24.
  15. Ragazzi E., Chinellato A., Pandolfo L., Froldi G., Caparrotta L., Prosdocimi M., Aliev G, and Fassina G. Atherosclerosis-related remodeling of aortic relaxation to purines in Watanabe Heritable Hyperlipidemic (WHHL) rabbits. J. Pharmacol. & Exper. Therapeutics (JPET), 1993; 266(2): 1091-1096.
  16. Caparrotta L., Pandolfo L., Chinellato A., Ragazzi E., Froldi G., Aliev G, and Fassina G. L-arginine does not improve endothelium-dependent relaxation in vitro Watanabe rabbit thoracic aorta. Amino Acids, 1993; 5: 403-411.
  17. * Chinellato A., Ragazzi E., Petrelli L., Paro M., Mironov A., and Aliev G Effect of cholesterol-supplemented diet in Heritable Hyperlipidemic Yoshida rats: Functional and Morphological characterization of thoracic aorta. Atherosclerosis, 1994; 106: 51-63.
  18. Cirillo R., Aliev G, Hornby E., and Prosdocimi M. Endothelium as a therapeutical target in peripheral occlusive arterial diseases. Consideration for pharmacological interventions. Pharmacological Research, 1994; 29(4): 293-311.
  19. * Chinellato A., Ragazzi E., Pandolfo L., Palermo Alvano A., Froldi G., De Biasi M., Caparrotta L., Aliev G, and Fassina G. Functional and Morphological characterization of thoracic aorta in Yoshida rats in different ages. J. Cardiovasc. Pharm., 1994; 24:216-228.
  20. Salvatico E., Aliev G, Novello D., and Prosdocimi M. Functional depression of isolated perfused rat heart mediated by activated leukocytes: Protective effect of Cloricromene. J. Cardiovasc. Pharmacol., 1994; 24: 638-647.
  21. Pandolfo L., Ragazzi E., Chinellato A., Froldi G., Caparrotta L., Aliev G, and Fassina G. Endothelial receptor defense in advanced atherosclerosis. Polish J. Pharmacol., 1994; 46(4): 350-351.
  22. Ragazzi E., Chinellato A., Pandolfo L., Froldi G., Caparrotta L., Aliev G, Prosdocimi M., and Fassina G. Endothelial nucleotide-mediated aorta relaxation in aged Watanabe rabbits. J. Cardiovasc. Pharmacol, 1995; 26: 119-126.
  23. * Aliev G, Miah S., Turmaine M., and Burnstock G. An ultrastructural and immunocytochemical study of thoracic aortic endothelium in aged Sprague-Dawley rats. J. Submicr. Cytol. Pathol., 1995; 27(4): 477-490.
  24. * Sala A., Aliev G, Rossoni G., Berti F., Buccellati C., Burnstock G., Folco G.C., and Maclouf J. Ultrastructural and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotriens in isolated heart of rabbit. Blood, 1996; 87(5): 1824-1832.
  25. * Aliev G, Ralevic V., and Burnstock G. Depression of endothelial nitric oxide synthase but increased expression of ET-1 immunoreactivity in rat thoracic aortic endothelium associated with long-term, but not short-term sympathectomy. Circ. Res., 1996; 79: 317-323.
  26. Ralevic V., Aliev G, and Burnstock G. Mesenteric and Hepatic vascular reactivity in Donryu rats with and without a cholesterol-supplemented diet. Eur. J. Pharmacol., 1996; 313: 221-227.
  27. Shankar A., Loizidou M., Aliev G, Fredericks S., Holt D., Burnstock G., and Taylor I. Raised ET-1 levels in patients with colorectal liver metastases. British J. Surgery, 1998, 85: 502-506.
  28. *Aliev G, Bodin P., and Burnstock G. Free radical generators changes inducible and endothelial nitric oxide synthase and ET-1 immunoreactivity in endothelial cells from hyperlipidemic rabbits. Molecular Genetics and Metabolism, 1998; 63: 191-197.
  29. Aliev G, Ragazzi E., Cirillo R., Bevilacqua C., Mironov A., Prosdocimi M., and Paro M. Cryodamage of the vessel wall accelerate the development of atherosclerotic lesions in the arterial vessels of Watanabe rabbits. J. Submicr., Cytol. Pathol, 1998; 30(3): 417-423.
  30. * Aliev G and Burnstock G. Watanabe rabbits with Heritable Hyperlipidemia: A model of Atherosclerosis. Histology and Histopathology, 1998; 13: 797-817.
  31. Aliev G, Ragazzi E., Smith M., Mironov A., and Perry G. Morphological features of regeneration of rabbit aortic endothelium after cryoinduced vascular damage. Journal of Submicr. Cytol. & Pathol. 1999:31(4), 495-502.
  32. * Aliev G, Shi J., Perry G., Friedland R.P., and LaManna J. C. Depression of constitutive nitric oxide synthase, but increased expression of inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of Donryu rats on a cholesterol-enriched diet. The Anatomical Record, 2000:260; 16-25.
  33. * Aliev G, Smith M.A., Turmaine M., Neal M.L., Friedland R.P., Perry G., LaManna J.C., and Burnstock G. Atherosclerotic lesions are associated with increased immunoreactivity for inducible Nitric Oxide Synthase and Endothelin-1 in thoracic aortic intimal cells of hyperlipidemic Watanabe rabbits. Experimental and Molecular Pathology, 2001, 71, 40-54.
  34. Aliev G, Seyidova D., Neal M.L., Jiong Shi J., Hernandez A., Folco G., Smith M.A., Perry G., LaManna J.C., and Friedland R. P. The effect of agonists and antagonists on the morphology of non-transformed human smooth muscle cell in vitro. Journal of Submicr. Cytol. Pathol. 2001 V. 33, No1-2, 141-149.
  35. Aliev G, Seyidova D., and Gasimov E.K. SEM-analysis of the mechanisms of the effect of Cloricromene on the processes of reendothelization of the aorta after cryodestruction. Azerbaijan Medical Journal, 2001, 4: 25-30.
  36. Aliev G, Samedov SK, Seyidova DY, Mironov A, Burnstock G, LaManna JC, Smith MA, Perry G, Gasimov EK. The morphological features of the development of atherosclerosis in Watanabe heritable hyperlipidemic rabbits (WHHL). Vita Medical Journal 1-2:11-16, 2001.
  37. * Aliev G, Smith M.A., Seyidova D., Neal M.L., Shi J., Loizidou M., Turmaine M., Perry G., Taylor I., Burnstock G., Friedland R.P., and LaManna J.C.. Increased expression of NOS and ET-1 immunoreactivity in human colorectal metastatic liver tumors is associated with selective depression of constitutive NOSs immunoreactivity in vessel endothelium. Journal of Submicr. Cytol. & Pathol, 2002 Vol. 34(1); 37-50.
  38. Aliev G Obrenovich ME., Seyidova D., Rzayev N., Aliyev A., Raina A.K., LaManna, J.C., Smith M.A. and Perry G. X-ray contrast media induce aortic endothelial damage, which can be prevented with prior heparin treatment. J. Submicr. Cytol. & Pathol. 2003, 35(3): 253-266.
  39. Aliev G, Castellani R., Peterson R., Burnstock G., Perry G., Smith M.A. Pathobiology of familial hypercholesterolaemic atherosclerosis. J. Submicr. Cytol & Pathology, 2004, 36(3-4):225-240.
  40. * Aliev G, Obrenovich ME. Seyidova D. and J.C. de la Torre. Exploring Ischemia-induced Vascular Lesions and Potential Pharmacological Intervention Strategies. Histology and Histopathology, 2005:20(1):261-73.
  41. Aliev G, Samedov S.KH., Obrenovich M.E., Mironov A.A., Burnstock G., LaManna J.C., Smith M.A. Perry G. and Gasimov E.K. Molecular Features of the Development of atherosclerosis in Watanabe Heritable Hyperlipidemic Rabbits. The Reports of the National Academy of Sciences of the Azerbaijan Republic, 2006, No2 (March-April):57-66.
  42. * Palacios H., Obrenovich ME., Gasimov E. and Aliev G Functional and Morphological characteristics of aortic endothelium by using different methods of their prevention after ischemia and hypoxia. Histology and Histopathology. 2010, submitted.
  43. * Palacios H., Obrenovich ME., Gasimov E. and Aliev G Ultrastructural mechanisms of non-reversible damage of the aortic endothelium after acute ischemia. Therapeutic Advances in Cardiovascular Disease 2010, submitted.
  44. * Palacios H., Obrenovich ME., Gasimov E., Morales L. and Aliev G The qualitative and quantitative criteria of the viability of the aortic endothelium after ischemia and following blood recirculation. Histology and Histopathology, 2010, submitted.

C: Reports of National Inst. of Technical Information (VINITI), MOSCOW, USSR:

  1. Aliev G and Mironov A. Ultrastructural mechanisms of non-reversible damage to the aortic endothelium after sudden death. Reports of VINITI, Moscow, Russia. 18.05.1988; 3824 (B88):11PP.
  2. Aliev G Scanning Electron Microscopic characteristics of intact aortic endothelium during different methods of preparation in normal conditions. Reports of VINITI, Moscow, Russia. 17.06.1988; 4767: 5PP.
  3. Aliev G and Mironov A. Morphological characteristics of aortic endothelium during different methods of prolonging viability after sudden death. Reports of VINITI, Moscow, Russia. 1989; 7769: 12 PP.
  4. Aliev G and Mironov A. Injury of aortic endothelium after ischemia and blood recirculation. Reports of VINITI, Moscow, Russia. 1989; 7750: 35 PP.
  5. Aliev G, Mironov A., and Stepanov A. Endothelial cell damage following exposure to X-ray contrast medium and methods of reduction. Reports of VINITI, Moscow, Russia. 1990; 3970 (B90): 27 PP.
  6. Mironov A., Aliev G, and Gurkin S. SEM analysis after the cryodestruction of rabbit aortic intima. The effect of Cloricromene on reendothelization. Reports of VINITI, Moscow, Russia. 1992; 1880 (B92): 10 PP.
  7. Mironov A., Aliev G, Rekhter M., and Gurkin S. Cryodestruction of the vessel wall accelerated the development of atherosclerotic lesions in the aorta of WHHL rabbits. Reports of VINITI, Moscow, Russia. 1992; 1883 (B92): 12 PP.
  8. Bedyaev E., Aliev G and Mironov A. Changes of aortic endothelium after the reduction of vessel lumen. Reports of VINITI, Moscow, Russia. 1993; 2885 (B93):16 PP.
  9. Solnyshkov S.K. and Aliev G The ultrastructural features of skin microvessels in patients with early stages of heart failure. Reports of VINITI, Moscow, Russia. 1993; 2890 (B93): 15 PP.
  10. Mironov A., Konkina E.A., Aliev G, and Pogorelov Yu.V. The ultrastructural features of luminal surface of the coronary artery of rabbits with genetic hyperlipidemia. In VINITI, Moscow, Russia. 11/15/1995; N1635- B95-16 PP.

PUBLISHED ABSTRACTS FROM MEETING PRESENTATIONS:

  1. Aliev G Ultrastructural mechanisms of non-reversible injury of aortic endothelium after sudden death. In: Thesis of the Conference of Young Scientist of Ivanovo State Medical Institute, Ivanovo, Russia, 1986, Abstr. Book, 1986: 30.
  2. Aliev G The injury of endothelium after ischemia. In: Thesis of the Scientific Conference, Ivanovo, Russia, 1986. Abstr. Book, 1986; III: 189.
  3. Rekhter M.D., Vyalov S.L., Aliev G, and Salapina O.A. Intercellular interactions in injury and reparative regeneration of vascular endothelium. In: Soviet Union Conference; "The Problems of Diagnosis, Prophylactics and treatment of Heart and Vessel Diseases". Moscow, Russia, Abstr. Book, 1986: 21.
  4. Aliev G Morphological Analysis of aortic endothelium after the sudden death of an organism during perfusion of vessel segments. In: Thesis of Reports, Ivanovo, Russia, 1987, Abstr. Book, 1987: 25.
  5. Aliev G, and Voronov S. Morphological and functional analysis of rat aortic endothelium in different conditions after the sudden death of the organism. In: Thesis of Reports, Ivanovo, Russia, Abstr. Book, 1988: 36.
  6. Mironov A.A., Mironov V.A., Rekhter M.D., Vyalov S.L., Aliev G, and Salapina O.A. Injury and regeneration of arterial and venous endothelium. In: Thesis of Reports of the Second Congress of Anatomy Histology and Embryology of Russian Federation, Moscow, Russia, Abstr. Book, 1988: 78-79.
  7. Salvatico E., Cirillo R., Paro M., Aliev G, and Prosdocimi M. Biochemical and physiological changes of peripheral ischemia and reperfusion in the rabbit. In: The 1991 FASEB Meeting. The FASEB J., 1991; II (5): A1277.
  8. Cirillo R., Salvatico E., Aliev G, Paro M., and Prosdocimi M. Effetto del Cloricromene in un modelle di ischemia periferica: Un possible effetto inhibitorio dell' attivazione lecocitaria. Minerva Angiologia, 1991; 2: 37.
  9. Aliev G, Cirillo R., Salvatico E., Paro M., and Prosdocimi M. Scanning Electron Microscopy (SEM) studies of microcirculation in skeletal muscle after ischemia and reperfusion in the rabbit. In: 9th International Congress of Thrombosis, Amsterdam, the Netherlands. Thrombosis and Homeostasis, 1991; 65(6): 1356.
  10. Aliev G, Bedyaev E., and Mironov A. Interaction between endothelial and blood cells in the arterial wall after chronic stenosis in the rat. In: 9th International Cong. Thrombosis. Amsterdam, the Netherlands. Thrombosis and Homeostasis, 1991; 65(6): 1086.
  11. Paro M., Cirillo R., Salvatico E., Aliev G, Prosdocimi M., Solda P., and Pantaleo E. Vascular Hemodynamic impedance and cardiac out-put in genetic model of atherosclerosis (WHHL rabbits). In: 9th International Symposium of Atherosclerosis, Chicago, Illinois, 6-11 October, 1991. Abstr. Book, 1991: 2125.
  12. Aliev G, Cirillo R., Paro M., Prosdocimi M., and Mironov A. Three-dimensional characteristics of intimal surface in newborn WHHL rabbits. In: 9th International Symposium of Atherosclerosis, Chicago, Illinois, 6-11 October, 1991. Abstr. Book, 1991: 138.
  13. Aliev G, Cirillo R., Paro M., Prosdocimi M., and Mironov A. Three-dimensional analysis of microvascular endothelial cells by mean of scanning electron microscopy. In: XYIII Italian National Congress of Electron Microscopy, 24-28 September, 1991. Padova, Italy. Abstr. Book of Padova University, 1991: 71-72.
  14. Aliev G and Mironov A. The effect of contrast medium on endothelial morphology. In: International Symposia. "BIOTECH" 1991 (Biotechnology of Growth Factors; Vascular and Nervous System), Milan Italy. May, 1991. Abstr. Book, 1991: 108.
  15. Aliev G, Cirillo R., Salvatico E., Paro M., Prosdocimi M., and Mironov A. Morphological analysis of peripheral arteries and hindlimb microcirculation in aged normal and WHHL rabbits. In: 64th Scientific Session of American Heart Association, 1991: 89.
  16. Cirillo R., Aliev G, Italiano G., and Prosdocimi M. Does the lack of Bradykinin effect been early marker of the development of atherosclerosis in peripheral vessels of WHHL rabbits? In: 64th Scientific Session of American Heart Ass. 1991: 2125.
  17. Paro M., Cirillo R., Salvatico E., Aliev G, and Prosdocimi M. Vascular Hemodynamic impedance (Zc) and cardiac output (CO) in aged WHHL rabbits. Pharmacological characterization. In: 64th Scientific Session of AHA, 1991: 2179.
  18. Mironov A., Mironov V., Rekhter M., Aliev G, Vyalov S., and Bannykh S. Standard area freeze denudation of the rat aortic endothelium: Quantitative in vivo assay of endothelial cell migration and proliferation. In: IX Arbeitstagung der Anatomischen Gesellschaft. Wurzburg, Germany. 2-4 October, 1991. Abstr. Book 1991: 20.
  19. Paro M., Cirillo R., Salvatico E., Aliev G, and Prosdocimi M. Vascular Hemodynamic impedance and cardiac output in aged WHHL rabbits. Pharmacological characterization. In: Scientific Session of American Heart Association: Scientific Conference on Functional and Structural Mechanisms of Vascular Control". Snowbird Conf. Center (Snowbird, Utah, USA. January 29-Febr. 01 1992. Abstr. Book, 1992: 40.
  20. Salvatico E., Cirillo R., Paro M., Siani G., Aliev G, and Prosdocimi M. Vascular and muscle alterations in a rabbit model of peripheral ischemia-reperfusion. In: 2nd International Symposium on Endothelium-Derived Vasoactive Factors, Basel, April 22-25, 1992. J. Vascular Research, 1992; 29(2): 193-194.
  21. Paro M., Cirillo R., Aliev G, Prosdocimi M., Solda P., Perlini S., and Bernardi L. Vascular Hemodynamic impedance and cardiac out-put in aged WHHL rabbits: A Pharmacological characterization. In: 13 Annual European Conference of Vascular Biology. Venice, Italy, July 10-14, 1992. Abstr. Book, 1992: 125.
  22. Salvatico E., Aliev G, Zatta A., Paro M., and Prosdocimi M. Cloricromene attenuate PMN-mediated myocardial impaired in isolated perfused rat heart. In: 65th Scientific Session American Heart Ass. November 16-19, 1992, New Orleans, St Louis, 1992: 126575.
  23. Fassina G., Dorigo P., Puglisis L., Aliev G, Mironov A., Chinellato A., and Ragazzi E. Functional and morphological variations in aorta of genetically hyperlipidemic YOS rats. In: 65th Scientific Session of American Heart Association, November 16-19, 1992, New Orleans, St Louis, 1992: 119728.
  24. Chinellato A., Ragazzi E., Pandolfo L., Froldi G., Aliev G, Caparrotta L., and Fassina G. Mechanisms of unimpaired ATP-induced aortic relaxation in WHHL rabbits. In: 65th Scientific Session of American Heart Association, November 16-19, 1992, New Orleans, St Louis, 1992: 119720.
  25. Aliev G, Mironov A., Mironov A (Jr.), Chinellato A., Pandolfo L., Ragazzi E., Caparrotta L., and Fassina G. Morphological alterations of arterial vessels in Pittsburg Yoshida rats with Heritable Hypercholesterolemia. In: Third Biennial Meeting in Basic Cardiovascular Biology, November 5-8, 1992. Abstr. Book, 1992: 258.
  26. Aliev G, Mironov A., Mironov A (Jr.), Cirillo R., and Prosdocimi M. Atherosclerotic lesions in aorta of Watanabe Heritable Hyperlipidemic (WHHL) rabbits are formed in embryogenesis. In: Third Biennial Meeting in Basic Cardiovascular Biology, November 5-8, 1992. Abstr. Book, 1992: 250.
  27. Prosdocimi M., Aliev G, and Salvatico E. Cloricromene inhibits leukocyte-mediated dysfunction in rat isolated heart. In: FASEB "Experimental Biology", 1993. New Orleans Louisiana, March 28-April 01, 1993. The FASEB J., 1993: (1); I: A345:1997.
  28. Chinellato A., Ragazzi E., Pandolfo L., Froldi G., Caparrotta L., Aliev G, Mironov A., and Fassina G. Serum lipids, functional and morphological characterization of thoracic aorta in genetic cholesterol-fed Heritable Hyperlipidemic Yoshida rats. In: International Conference HDL-Cholesterol and triglycerides: Role in Coronary Heart Disease and Laboratory Measurements, Washington DC. April 2-3, 1993. Abstract Book, 1993:105.
  29. Pandolfo L., Chinellato A., Ragazzi E., Froldi G., Caparrotta L., Aliev G, and Fassina G. Protective role of HDL on atherogenesis in Heritable Hyperlipidemic Yoshida rats. Comparison with Heritable Hyperlipidemic Watanabe rabbits. In: International Conference HDL-Cholesterol and triglycerides: Role in Coronary Heart Disease and Laboratory Measurements, Washington DC. April 2-3, 1993. Abstract Book, 1993:107.
  30. Chinellato A., Ragazzi E., Aliev G, Pandolfo L., Froldi G., Caparrotta L., and Fassina G. Functional and morphological characterization of thoracic aorta in a rat model of mixed (exogenous and endogenous) Hyperlipidemia. In: 62nd European Ath. Soc. Congress, Jerusalem, Israel, September 5-9, 1993. Abstract Book, 1993: 56.
  31. Fassina G., Ragazzi E., Chinellato A., Pandolfo L., Froldi G., Aliev G, and Caparrotta L. Mechanism of unimpaired endothelial ATP-induced aortic relaxation in isolated aorta from hypercholesterolaemic rabbits. In: 5th Join Meeting Between the British and Italian Societies of Pharmacology, September 13-16, 1993, Rome, Italy. British J. Pharmacology, VIII (Proceeding Suppl): 271P, 1994.
  32. Mironov A. (Jr.), Aliev G, and Mironov A. The Morphological features of coronary arteries in Watanabe Heritable (WHHL) rabbits and Yoshida Hyperlipidemic rats. In: 3rd International Young Cardiology Days. November 17-19, 1993, Istanbul- Turkey. Abstract Book, 1993, P.43.
  33. Aliev G, Mironov A.A., Bannykh S.I., Mironov A. (Jr.)., Cirillo R., Paro M., Salvatico E., and Prosdocimi M. Age-dependent pathology of vascular wall in WHHL rabbits: SEM and TEM studies. In: International Congress of Angiology, Paris, 15-18 May, 1992. Abstract Book, 1992, PP. 13-15.
  34. Vigano T., Acconazzo M.R., Hernandez A., Galbait E., Giovanazzi S., Folco G.C., Aliev G, Sanlinelli E., and Nicosia S. LTD4 induced cytosolic Ca2+ changes and contraction in cultured human bronchial smooth muscle cells. In: 9th International Conference on Prostaglandin’s and Related Compounds, Florence, Italy, June 6-10, 1994. Abstract Book, 1994: 114.
  35. Aliev G, Bodin P., Mironov A., and Burnstock G. Impaired constitutive NOS activity by endogenous and exogenous free radicals in endothelial cells (EC) from Watanabe Heritable Hyperlipidemic (WHHL) rabbits. Protective effect of Morin. In: ECBO Meeting, 5-8 April, 1995. Germany. European Journal of Cell Biology, 1995; S: P.213: Abstract 665.
  36. Aliev G and Burnstock G. Distribution of constitutive and inducible NOS and ET-1 immunoreactivity in thoracic aortic endothelium in Watanabe heritable Hyperlipidemic (WHHL) rabbits. In: 64th Congress of the European Atherosclerosis Society, Utrecht, The Netherlands, June 10-13, 1995. Atherosclerosis, 1995:115; S61: P225.
  37. Aliev G, Pollock J., Mironov A., and Burnstock G. Distribution of Endothelial and Macrophage specific NOS and ET-1 immunoreactivity in human aortic intima. In: 64th Congress of the European Atherosclerosis Society, Utrecht, The Netherlands, June 10-13, 1995. Atherosclerosis, 1995: 115; S61: P224.
  38. Aliev G, Bodin P., Mironov A., and Burnstock G. Impaired constitutive NOS activity by endogenous and exogenous free radicals in endothelial cells (EC) from Watanabe Heritable Hyperlipidemic (WHHL) rabbits. Protective effect of Morin. In: 64th Congress of the European Atherosclerosis Society, Utrecht, The Netherlands, June 10-13, 1995. Atherosclerosis, 1995: 115; S61: P4; 209.
  39. Vigano T., Accomazzo M.R., Hernandez A., Galbiati E., Aliev G, Nicosia S., and Folco G.C. Contraction and cytosolic calcium in human bronchial smooth muscle cells in culture. In: First European Congress of Pharmacology, Milan, June 16-19, 1995. Pharmacological Res., 1995; 31: Suppl., P.358.
  40. Mironov A., Aliev G, and Pogorelov Yu.V. The Ultrastructural Mechanisms of the atherosclerotic lesions on the WHHL rabbits arterial vessels in the regions of unstable Hemodynamic tensions. In: Union Symposium “Lipoprotein and Atherosclerosis”. November 1995, Sankt-Petersburg, Abstract Book,, Russia, 1995, P.65.
  41. Shankar A., Aliev G, Loizidou M., Fredericks S., Holt D., Boulos P.B., Burnstock G., and Taylor I. Elevated ET-1 levels in patients with colorectal liver metastases. In: Surgical Research Society Meeting of Great Britain. June, 1996. British J. Surgery, 1996; 83: 1628.
  42. Smith M.A., Aliev G, Nunomura A., and Perry G. Mitochondria abnormalities and metabolic dysfunction in Alzheimer’s disease. In: Oxygen Club of California 1999 World Congress. Platform Presentation. Abstr. Book, 1999, P.82.
  43. Aliev G, Smith M.A., Vinters H., Johnson A.B., Nunomura A., and Perry G. Mitochondria Abnormalities mark vulnerable neurons in Alzheimer disease. In: The Annual Meeting of the Am. Ass. Neuropathologist. Portland, OR, June 17-20, 1999, Platform Presentation. Journal of Neuropathology and Experimental Neurology, 1999; 58: 511.
  44. Perry G, Nunomura A, Takeda A, Russell RL, Aliev G, Raina AK, Smith MA. Looking for death in all the wrong places: apoptosis in Alzheimer disease. Int. Soc. Neurochem Symposia. on Neuronal Apoptosis, p. 31, 1999.Platform Presentation.
  45. Shi J., Perry G., Aliev G, Smith M.A., and Friedland R.P. Basic fibroblast growth factor and serum amyloid P component binding to amyloid deposits in a transgenic animal model overexpression beta-amyloid. Evidence for integrity of the blood-brain barrier. Society for Neuroscience Abstracts 1999; 25:1860.
  46. Perry G., Aliev G, Nunomura A., and Smith M.A. Mitochondria abnormalities and metabolic dysfunction in Alzheimer disease. In: 6th Meeting of the Portuguese Society for Neuroscience, p. 33, 1999. Platform Presentation.
  47. Perry G, Aliev G, Nunomura A, Smith MA. Metabolic dysfunction is the source of oxidative damage in Alzheimer disease. In: 4th International Symposium on Medicinal Chemistry of Neurodegenerative Diseases, p. 61, 2000. Platform Presentation.
  48. Aliev G, Shi J., LaManna JC., Friedland RP., and Lamb BT. Mitochondria Abnormalities hallmark vulnerable neurons in YAC transgenic mice. In: World Alzheimer Congress 2000, Washington D.C. Neurobiology of Aging 21:1S, S 266, P. 1222, 2000.
  49. Aliev G, Shi J., LaManna JC., Lamb BT, and Friedland RP Atherosclerotic-like changes of the wall of cerebral microvessels in transgenic mice overexpressing amyloid ß. In: World Alzheimer Congress 2000, Washington DC. Neurobiology of Aging 21:1S, S 267, P. 1224, 2000.
  50. Perry G., Hirai K., Aliev G, Nunomura A., Siedlak S.L. and Smith M.A. Mitochondria abnormalities in Alzheimer Disease. In: World Alzheimer Congress 2000, Washington DC, Neurobiology of Aging, 21:1S, S213, P. 969, 2000. Platform Presentation.
  51. Aliev G, J. Shi, G. Perry, B. T. Lamb, J. C. LaManna, and R. P. Friedland. Neuronal Mitochondrial Abnormalities In Yeast Artificial Chromosome (YAC) Transgenic Mice Overexpressing Amyloid Precursor Protein (APP). In: Society for Neuroscience Abstracts 2000, 30(1): 26; 301.4. Platform Presentation.
  52. Shi J., Perry G., Berridge M. S., Aliev G, Smith M. A., LaManna J. C., and Friedland R. P. Labeling of cerebral amyloid ß deposits in vivo using nasally administrated basic fibroblast growth factor. Society for Neuroscience Abstracts 2000, 30(1):26; 110.7. Platform Presentation.
  53. Perry G., Hirai K., Nunomura A., Aliev G, Siedlak S.L., and Smith M.A. Oxidative stress and mitochondrial abnormalities in Alzheimer Disease. In: Brain Pathology, 2000:10; 275. Platform Presentation.
  54. Perry G., Aliev G, Nunomura A., and Smith M.A. The source of oxidative damage in Alzheimer’ Disease. In: First International Conference; Metals and Brain, 2000, P.37.
  55. Perry G., Atwood C.S., Sayre L.M., Nunomura A., Aliev G, Hirai K., and Smith M.A. Redox active Metals play a key role in modulating neuronal oxidative balance. In: First International Conference; Metals and Brain, 2000, P.137.
  56. Smith M.A., Nunomura A., Sayre L.M., Rottkamp C.A., Zhu X., Raina A.K., Hirai K., Friedland R.P., Shi J., Aliev G, Wataya T., Scimohama S., Atwood C.S., and Perry G. Fundamental Role of oxidative stress and stressors in Alzheimer disease. In: Dementia, 14:232 (2000). Platform Presentation.
  57. Perry G, Nunomura A., Friedlich A., Boswell M.V., Brazdil L., Jones P.K., Rottkamp C.A., Zhu X., Raina A.K., Hirai K., Friedland R.P., Shi J., Aliev G, Cash A., Russell R.L., Wataya T., Scimohama S., Atwood C.S., and Smith M.A. Factors Controlling Oxidative Damage in Alzheimer Disease: Metals and Mitochondria. In: Society of Free Radical Research International, 2000, P. 57; 021-1, (2000). Platform Presentation.
  58. Perry G., Aliev G, Nunomura A., and Smith M.A. The Source of oxidative damage in Alzheimer Disease. In: Journal of Alzheimer’s disease, 2: 336-337, 2000.
  59. Perry G., Atwood C.S., Sayre L.M., Nunomura A., Aliev G, Hirai K., and Smith M.A. Redox active metals play a key role in modulating neuronal oxidative damage. In: Journal of Alzheimer’s Disease, 2: 329, 2000. Platform Presentation.
  60. Smith M.A., Atwood C.S., Sayre L.M., Nunomura A., Aliev G, Hirai K., and Perry G. Metal-catalyzed redox chemistry underlies oxidative damage in Alzheimer disease. In: Workshop on Copper and Prion Disease, P.20, 2001.
  61. Aliev G, Perry G., Lamb B.T., Seyidova D., Neal M.L., Siedlak S.L., LaManna J.C., Smith M.A., and Friedland R.P. Aged YAC AßPP transgenic mice develop atherosclerotic lesions and mitochondria DNA deletions in brain microvessels without exogenous cholesterol supplementation. In: Society for Neuroscience Abstracts 2001; 752.12.
  62. Gasimov E.K., Perry G., and Aliev G The effect of experimental edema on the permeability of microvessels of the sciatic nerve. In: Society for Neuroscience Abstracts 2001; P.561.6.
  63. Perry G, Hirai K, Nunomura A, Aliev G, Siedlak SL, Smith MA. Abnormalities in oxidative metabolism in Alzheimer’s disease. J. Neurochem 78 (Suppl 1):103, 2001.
  64. Aliev G, G. Perry, D. Seyidova, B.T. Lamb, M.L. Neal, S.L. Siedlak, M.A. Smith, J. LaManna, and R.P. Friedland. Aged YAC AßPP Transgenic Mice Develop Atherosclerotic Lesions and Mitochondrial DNA Deletions in Brain Microvessels. In: Third World Congress on Vascular factors in Alzheimer’s Disease. Platform Presentation (Kyoto, Japan, April 7-10, 2002). Abstract Book, 2002, P.102.
  65. Aliev G Mitochondrial abnormalities are the central target for Alzheimer’s disease and Alzheimer’s disease-like pathology: Recent advances. In: 8th Annual Canine Cognition, Aging, and Neuropathology Conference. La Quinta Cultural Center at the Los Poblanos Inn, Albuquerque, New Mexico, June 3-4, 2002. Platform Presentation.
  66. Aliev G, G. Perry, D. Seyidova, B.T. Lamb, M.L. Neal, S.L. Siedlak, M.A. Smith, J. LaManna, and R.P. Friedland. The Role of Mitochondria Failure in the Development of AD-like Pathology in an Aged Transgenic Mouse Model of AD. In: 8th International Conference on Alzheimer’s Disease and Related Disorders (July 20-25, 2002, Stockholm, Sweden). Platform Presentation. Neurobiology of Aging, 2002, Vol. 23:No. 1S: S414; PP-1525.
  67. Shi J., Perry G., Berridge M. S., Aliev G, Smith M. A., LaManna J. C., and Friedland R.P.. In Vivo labeling of cerebral amyloid ß deposits using intranasal bFGF and SAP in a transgenic mouse model. In: 8th International Conference on Alzheimer’s disease and Related Disorders (July 20-25, 2002, Stockholm, Sweden). Platform Presentation. Neurobiology of Aging, 2002, Vol. 23:No. 1S: S276; PP-1032.
  68. Aliev G, D. Seyidova, B.T. Lamb, M.L. Neal, S.L. Siedlak, M.A. Smith, J. LaManna, E. Head, G. Perry and Cotman C.W. The role of mitochondria failure in the development of AD-like pathology in an aged Tg mouse model of AD. In: Soc. for Neuroscience, 2002. P. 778.6.
  69. Seyidova D., G. Perry, B.T. Lamb, M.L. Neal, S.L. Siedlak, M.A. Smith, J. LaManna, E. Head, C.W. Cotman, and Aliev G The role of mitochondrial DNA deletions in the development of Alzheimer’s -like pathology in an aged transgenic mouse model of AD. In: Society for Neuroscience, 2002. P.621.10 (Platform Presentation).
  70. Shi J., Seyidova D., G. Perry, B.T. Lamb, M.L. Neal, S.L. Siedlak, M.A. Smith, J. LaManna, Friedland R.P., and Aliev G Neuronal mitochondria abnormalities in a transgenic mouse model overexpressing amyloid beta. In: Society for Neuroscience, 2002. P. 295.20.
  71. Perry G., Zhu X., Aliev G, Avila J., Atwood C.S., Nunomura A., and Smith M.A. Oxidative Stress, a Mediator of Alzheimer Disease. In: International Conference on Cell and Molecular Biology of Alzheimer Disease: Abstract Book, 2002, P.5.
  72. Aliev, G., Seyidova, D., Lamb, B.T., Smith, M.A., Perry, G. Atherosclerotic lesions and mitochondrial DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. In: Abstract Book of 6th International Conference on Stroke and 3rd Conference of the Mediterranean Stroke Society, Monte Carlo, Monaco, March 12-15, 2003). Platform Presentation. PP. 3-4.
  73. LaManna J.C., K. Xu, M. A. Puchowicz, K. Radhakrishnan, D. Seyidova, J. Shi, Aliev G and R.P. Friedland. Age-dependent features of cerebral blood flow in APOE-deficient mice. In: The Second International Conference on Cerebral Amyloid Angiopathy (CAA). December 4-6, 2002. Newcastle Upon Tyne, United Kingdom. Abstract Book, 2002, P.8.
  74. Aliev G, Lamb B.T., Smith M.A. and Perry G. Atherosclerotic Lesions and Mitochondrial DNA Deletions in Brain Microcirculatory Systems as a Central Target for the Development of Human AD and AD-Like Pathology in Aged Transgenic Mice. The 7th Congress of the European Federation of Neurological Societies, Helsinki, Finland (August 31-September 02, 2003). 2003:A883.00
  75. Aliev G, Smith M.A. and Perry G. Vascular Hypoperfusion, Mitochondria Failure and Oxidative Stress in Alzheimer’s disease. In: The First International Congress of the International Society for Vascular Behavioral and Cognitive Disorders (VAS-COG), Goteborg, Sweden, 28-31 August 2003. Platform Presentation. P.21, 2003.
  76. Perry G., D. Seyidova, B.T. Lamb, Smith M.A. and Aliev G Are Mitochondrial the Central Target for the Development of Alzheimer Disease and AD-Like Pathology in Aged Transgenic Mice? In: United Mitochondrial Disease Foundation Symposia, 2003 (Platform Presentation). In: Mitochondria, 2003, P. 27.
  77. Aliev G and Burnstock G. Increased expression of NOS and ET-1 immunoreactivity in human colorectal metastatic liver tumors and metastatic brain tumor but not benign brain tumor is associated with selective depression of constitutive NOS immunoreactivity in vessel endothelium: New Target for the Drug Treatment? Selected Platform Presentation. Development and Strategies for News Cancer Drug (San Diego, October, 2003).
  78. Liu J. E., E. Head, D. Seyidova, M.A. Smith, C. W. Cotman, G. Perry, Aliev G and Ames B.N.. Age-Associated neurodegeneration and Mitochondrial Decay: effects of mitochondrial metabolites acetyl–L–Carnitine and R–Lipoic acid in old rats. In: Society Neuroscience Annual Meeting. Program No. 874.10 (New Orleans, 2003).
  79. Aliev G, M.A. Smith, G. Perry and G. Burnstock. Increased expression of NOS and ET-1 immunoreactivity in human colorectal metastatic liver tumors and metastatic brain tumors but not benign tumor is associated with selective depression of constitutive NOS immunoreactivity in vessel endothelium: New Target for the Drug Treatment? In: 8th Inter Conf on Endothelin, November 23-26, 2003, Tsukuba, Japan. P. 100.
  80. Aliev G, M.A. Smith, G. Perry and G. Burnstock. Atherosclerotic Lesions are Associated with Increased Immunoreactivity for inducible NOS and ET-1 in Thoracic Aortic Intimal Cells of Hyperlipidemic Watanabe Rabbits. In: 8th International Conference on Endothelin, November 23-26, 2003, Tsukuba, Japan. P.61.
  81. Aliev G, M.A. Smith and G. Perry G. Hypoperfusion, Mitochondria Failure, Oxidative Stress and Alzheimer Disease. Plenary Lectures. In: “XI International Symposium on Stroke and Lipoprotein Abstract Book, Martin Slovak Republic, 2003: pp. 3.
  82. Perry G, Siedlak SL, de la Torre JC, Aliev G, Smith MA. Vascular and metabolic abnormalities in Alzheimer disease. 3rd Inter. Congress on Vasc. Dementia, p. 31, 2003.
  83. Aliev G, Perry G. J. Liu, M.E. Obrenovich, M.A. Smith, B. N. Ames and J.C. de la Torre. The primary pathogenic role of vascular hypoperfusion, mitochondria failure and oxidative stress in Alzheimer’s disease. Restorative Neurology and Neuroscience, 21 (5-6): 263, 2003. In: International Symposia “Brain Aging and AD: Neurological Restoration”. Havana, Cuba, February 24-27, 2004.
  84. de la Torre J.C., Emmerling M.R., Stefano G.B. and Aliev G A rat model of MCI upregulates nitric oxide and precedes memory loss and Abeta 1 – 40 accumulations after chronic brain hypoperfusion. Restorative Neurology and Neuroscience, 21 (5-6): 263, 2003. In: International Symposia “Brain Aging and AD: Neurological Restoration”. Havana, Cuba, February 24-27, 2004.
  85. Smith M.A., Zhu X., Casadesus G., Aliev G, Ogawa O., Nunomura A., Takeda A., Joseph J.A., Peterson R.B. and Perry G. Alzheimer Disease: Causes, Consequences, and Surprises. Biogerontology 4 (Suppl 1): 88-89, 2003.
  86. Perry G., Cash A.D., Aliev G, Siedlak S.L., Raina A.K., Nunomura A., Vinters H.V., Johnson A.B., Castellani R.J. and Smith M.A. Microtubule reduction found in Alzheimer disease and aging is independent of TAU abnormalities. In: Annual Meeting of American Neuropathology Society. J. Neuropathology & Experimental Neurology 62: 582, 2003.
  87. Aliev G, Seyidova D., Smith M.A., Perry G. and de la Torre J.C. Vascular hypoperfusion and mitochondria abnormality induce oxidative stress that appeared to be a key factor for the development of Alzheimer’s disease. In: XIII International Vascular Biology Meeting, 06/1-5, 2004 in Toronto, Canada. Cardiovasc. Pathol. 13:26-27, 2004.
  88. de la Torre J.C. and Aliev G Vascular Nitric Oxide: A Key Molecule in the pathogenesis of Alzheimer’s disease? In: 9th International Conference on Alzheimer’s disease and Related Disorders, July 17-22, 2004, Philadelphia, USA. Neurobiology of Aging 25:S2(S 50); S3-04-02, 2004.
  89. Aliev G, S. Siedlak, M. Smith, A. Aliyev, N. Rzayev, J. de la Torre, G. Perry. Vascular and metabolic failure in Alzheimer’s disease. In: 9th International Conference on Alzheimer’s disease and Related Disorders, July 17-22, 2004, Philadelphia, USA. Neurobiology of Aging 25:S2(S 61); 03-04-07, 2004.
  90. Rzayev N., Burnstock G. and Aliev G The Development of Atherosclerotic Lesions in Watanabe Heritable Hyperlipidemic Rabbits is Associated with the Overexpression of Endothelin-1 Immunoreactivity. In: Proceedings of the 11th Int. Symps., “New Frontiers of Neurochemistry and Neurophysics on Diagnosis and Treat. Neurol. Dis.” in Memory of Vincenzo Lombardi (Martin, Slovakia, December 4-7, 2003). J. Alzheimer’s Disease, 2004 V.6: 562-563.
  91. Aliev G, Obrenovich M. E., Smith M.A., de la Torre J.C. and Perry G. Hypoperfusion, mitochondria failure, oxidative stress and Alzheimer disease. In: Proceedings of the 11th International Symposium, “New Frontiers of Neurochemistry and Neurophysics on Diagnosis & Treatment of Neurological Diseases” with participation of the Inter. Society for Neurochemistry (ISN), JAD, 2004 V.6:548-549.
  92. Aliyev A., Burnstock G. and Aliev G Age-Dependent Features of Nitric Oxide Synthase Immunoreactivity During the Development and Progression of Atherosclerosis in Watanabe Hyperlipidemic Rabbits. In: Proceedings of the 11th International Symposium. J. Alzheimer’s Disease, 2004 V.6 (5):549-550.
  93. Cash A.D., Aliev G, Siedlak S.L., Raina A.K., Nunomura A., Vinters H.V., Johnson A.B., Castellani R.J. Smith M.A. and Perry G. Microtubule diminution in Alzheimer disease and aging is independent of abnormalities in TAU. In: 2004 Annual Irwin H. Lepow Student Research Day Meeting, CWRU. In: Irwin H. Lepow Student Research Day, P20:2004.
  94. Seyidova D., Siedlak S.L., Obrenovich M.E., Head E., Cotman C.W., Liu J.N., Ames B.N., Smith M.A., Perry G., de la Torre J.C., and G. Aliev. The Mitochondria DNA Deletion, Increased in Aged Dog Brain, Can Be Diminished Following Administration of Supplemental Antioxidants and Mitochondrial Cofactors. In: Society Neuroscience Annual Meeting. Program No. 1017.9 (San Diego 2004).
  95. Perry G., Honda K., Liu Q., Moreira P.I., Aliev G, Siedlak S.L., Harris P.L., Zhu X. and Smith M.A. Homeostatic regulation of chronic oxidative insult in neurodegenerative diseases. Journal of Neurochemistry, 2004; 90 (Suppl 1):108.
  96. Perry G., Harris P.L.R., Aliev G, Sayre L.M., Liu Q., Honda K. and Smith M.A. Oxidative stress and neurodegeneration. Abstract Book: In: 8th International Symposium on the Maillard Reaction, 2004: P 37.
  97. Perry G., Aliev G, Zhu X., Smith M.A. Oxidative Stress in Alzheimer disease: Consequence or Initiator of Pathogenesis. Abstract Book: In: Korean Conference on Innovative Science and Technology, 2004: [KCIST], p. 38a.
  98. Aliev G and Burnstock G. The Role of Nitric Oxide and ET-1 in the Pathobiology of Cardiovascular Diseases, Tumors and Neurodegeneration: New Target for the Drug Treatment? In: 7th International Conference of Anticancer Research, Corfu, Greece, 25-30 October, 2004, Plenary Lecture. In Vivo, 2004.
  99. Perry G, Honda K, Liu Q, Aliev G, Siedlak SL, Harris PLR, Zhu X, Smith MA. Stress and homeostatic regulation of oxidative damage in neurodegenerative disease. Free Radical Biol Med 36 (S.1): S9, 2004.
  100. Aliev G, G. Perry, J. Liu, M.A. Smith, S.G. Chen, B.N. Ames and J.C. de la Torre. The primary pathogenetic role of vascular contains vasoactive substances, hypoperfusion, mitochondria failure and oxidative stress in aging and Alzheimer disease. In: Alzheimer’s Association International Conference on Prevention of Dementia (June 18-21, 2005, Washington, D.C.). In: Alzheimer’s & Dementia, 2005:1(1); S1, S31: P-074.
  101. Aliev G, Perry G., Smith M.A., Chen S.G., de la Torre J.C. and Burnstock G. The Role of Nitric Oxide and ET-1 in the Pathobiology of Cardiovascular Diseases, Tumors and Neurodegeneration. In: 9th International Conference on Endothelin (Park City, Utah, USA, September 11-14, 2005). PO21. pp.39.
  102. de la Torre J.C. and Aliev G Vascular nitric oxide is a critical molecule in spatial memory function during chronic brain hypoperfusion. Findings from an experimental model of MCI. In: International AD conference in Sorrento (March, 2005 Italy). Plenary Invited Lecture. Abstract Book, 2005.
  103. Aliev G, Smith M.A., Perry G. Chen S.G., and de la Torre J.C. Vasoactive substances, hypoperfusion, mitochondria failure and oxidative stress in aging and AD. In: 4th international congress on Vascular Dementia (VD). Invited lecture. Abstract Book, 2005, P5.
  104. Honda K., Smith M.A., Aliev G, Moreira P.I., Nunomura A., Harris PLR, Siedlak SL and Perry G. The role of oxidative insult and neuronal survival in chronic neurodegenerative disease. In: 4th international congress on Vascular Dementia. Abstract Book, 2005, P6.
  105. Aliev G, Smith M.A. and Perry G. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice? J. Neurological Sciences, 2005, 229:354-355.
  106. de la Torre J.C. and Aliev G Alzheimer’s disease is a vascular disorder with neurological consequences? J. Neurological Sciences, 2005, 229:305-306.
  107. Perry G., Siedlak SL de la Torre J.C., Smith M.A. and Aliev G Vascular and metabolic abnormalities Alzheimer’s disease. J. Neurological Sciences, 2005, 229:375-375.
  108. Moreira P.I., Siedlak SL, Santos M.S., Oliveira C.R., Fujioka H., Tabaton M., Nunomura A., Aliev G, Szweda L.I., Zhu X.,, Smith M.A. and Perry G. Mitochondrial Autophagocytosis in Alzheimer’s Disease. In: International Conference of AD (Madrid Spain, July 2006). Alzheimer’s & Dementia 2006; 2 (Suppl 1): S79.
  109. Aliev G, Perry G, Shenk JC, Puchowicz M, Xu K, Siedlak SL, Obrenovich ME, Smith MA, Friedland RP, Ames BN, Liu J, de la Tore JC, LaManna JC and Koistinaho J. The primary pathogenetic role of vascular hypoperfusion, and oxidative stress in Alzheimer disease In: 76th Congress of European Atherosclerosis Society (EAS) Helsinki, Finland, June 10-13, 2007). EAS 2007 Helsinki, June 10-13, 2007. Atherosclerosis, 2007 (Suppl), V8 (1) PO13:P357, Page 105.
  110. Aliev G, Puchowicz M., Xu K., Shenk JC, Smith M.A., Siedlak S.L., Obrenovich M.E., de la Tore J.C., Friedland R. P., Perry G, and LaManna J.C. APOE deficiency induces age-dependent brain hypoperfusion and neuronal-glial and microvascular damage in mice. In: 8th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2007). Austria Salzburg, (March 14-18, 2007) In: Proceeding 8th International Conference AD/PD 2007, P545. In: Neurodegenerative Diseases 4 (Suppl 1):182 (2007).
  111. Perry G, Moreira PI, Siedlak SL, Santos MS, Oliveira CR, Fujioka H, Tabaton M, Nunomura A, Aliev G, Szweda L.I. and Smith MA. Mitochondrial autophagocytosis in Alzheimer disease. In: Experimental Biology 2007, The FASEB Journal. 2007; 21:126.6. Program Abstract #167.3.
  112. Aliev G, Shenk J.C., Liu J., Puchowicz M., Xu K, Smith MA., Siedlak S.L, Obrenovich M.E., Ames B.N., de la Torre J.C., Koistinaho J., LaManna J. C., and Perry G. Preventative effect of mitochondrial antioxidants in ApoE deficiency mouse model of brain hypoperfusion. Invited Lectures. In: 5th International Congress on Vascular Dementia, Budapest, Hungary, November 8-11, 2007. Abstract Book, 2007, P.78.
  113. Perry G., Ames B.N. and Aliev G Is oxidative stress an initiator of mitochondrial failure and vascular hypoperfusion during aging and Alzheimer disease? Present and future. Invited Lectures. In: 5th International Congress on Vascular Dementia, Budapest, Hungary, November 8-11, 2007. Abstract Book, 2007, P.76.
  114. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer disease. In: 5th International Congress on Vascular Dementia, Budapest, Hungary, November 8-11, 2007. Abstract Book, 2007, P.89.
  115. Perry G., Moreira P.I., Nunomura A., Harris P.H., Zhu X., Smith M.A. and Aliev G Abnormalities in protein RNA and Metal Trafficking Underlie oxidative Damage in Alzheimer’s Disease. In: 2007 International Conference “Current Hypothesis on Alzheimer’s Disease”. Abstract Book, 2007, P32.
  116. Perry G., Honda K., Nunomura A., Moreira P.I., Zhu X., Smith M.A. and Aliev G Mechanism of Mitochondrial Dependent Metal-Catalyzed Oxidative Stress in Alzheimer’s Disease. In: Philip Morris External Research Program Symposium: “Regulatory Circuitry”, 2007, P17.
  117. Aliev G, Liu J., Puchowicz M., Xu K., Siedlak S.L., Obrenovich M.E., Shenk J.C., Smith M.A., Gasimov E., LaManna J.C., Ames B.N., Perry G.. Does the Oxidative Stress and Cerebral Atherosclerosis Initiate Brain Hypoperfusion and the Development of Alzheimer Disease? In: 77th Congress of European Atherosclerosis Society (EAS) Istanbul Turkey, April 26-29, 2008. Atherosclerosis Suppl., 2008, V9 (1), PO33:154p (PO33-560).
  118. Aliev G, Burnstock G. and Perry G. The Key Role of Nitric Oxide and ET-1 in the Pathobiology of Cardiovascular Diseases, Tumors and Neurodegeneration: New Target for the Drug Treatment? Invited Lecture. In: 1st International Conference on Drug Design and Discovery, (ICDDD 2008) Dubai UAE, 3 - 6 February, 2008. Abstract Book, 2008, P35.
  119. Perry G., Moreira P.I., Shenk J.C., Aliev G and Smith M.A. Oxidative Window to Alzheimer Disease Therapeutics. Invited Lecture. In: 1st International Conference on Drug Design and Discovery, (ICDDD 2008) Dubai UAE, 3 - 6 February, 2008. Abstract Book, 2008, P45.
  120. Aliev G, Shenk J.C., Fischbach K., Perry G. and Ames B.N. The primary pathogenetic role of vascular hypoperfusion, mitochondria failure and oxidative stress in aging and Alzheimer disease. In: In: 2008 Joint Annual Meeting of American Society for Investigative Pathology (ASIP), American Association of Neuropathologist (AANP) and North American Vascular Biology Organization (NAVBO). (San Diego, CA, April 5-9, 2008). Experimental Biology 2008, The FASEB Journal. 2008;22:167.3.
  121. Aliev G, Shenk J.C., Fischbach K., Cobb C.J., Pacheco G.J., Gasimov E. and Perry G. Cerebral hypoperfusion-induced oxidative stress and mitochondrial failure as initiators of aging and Alzheimer’s disease pathology ICAD 2008 Conference, Chicago, IL, USA. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 2008, v.1 (4) Suppl. Page T721.
  122. Moreira P.I., Santos M.S, Siedlak S.L., Harris P., Smith M.A., Aliev G, Perry G, and Oliveira C.R. Mitochondrial dysfunction in Alzheimer disease. ICAD 2008 Conference, Chicago, IL, USA. P4-185. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 2008, v.1 (4) Suppl. Page T725.
  123. Aliev G Oxidative Stress-Induced Mitochondrial Failure and Vasoactive Substances as Key Initiators of Pathology Favor the Reclassification of Alzheimer Disease as a Vasocognopathy. In: ICAD 2008 Conference, Chicago, IL, USA. HOT TOPIC: Control/Tracking Number: 08-HT-3584-ALZ.
  124. Aliev G, Morales L.A., Obrenovich M.A., Fischbach K., Gasimov E. and Perry G. The Primary Pathogenetic Role of Oxidative Stress Induced Mitochondria Failure and Vascular Hypoperfusion In Aging and Alzheimer Disease: A Lesson from the Past 100 Years. 2nd WFSBP Asia-Pacific Congress and 30th Annual Meeting of JSBP Toyama (Japan) Sept.11-13, 2008: Biomarkers for early detection and differentiation of Dementia Disorders". The World Journal of Biological Psychiatry 2008,V. 9 (S1) S-08-04.
  125. Aliev G, Moreira P., Siedlak S.L., Smith M.A., Cobb C.J., Ferrer D., Yacaman M.J. and Perry G. Evidence of Increased Copper and Iron but not Zinc in Alzheimer’s Disease: Energy Dispersive X-ray Spectroscopy (EDS) Elemental Microanalysis. In: 13th International Meeting on Trace Elements in Man and Animals (TEMA 13). Plenary Lectures. Abstract Book 2008, P.53.
  126. Lipsitt A., Palacios H.H., Fischbach K., Morales L., P. H. Reddy and Aliev G Mitochondria as a Primary Target for Liver and Neuronal Lesions During Chronic Ethanol Feeding in Synomolgus Macaque Monkeys. In: Behavior, Biology, and Chemistry; Translational Research in Addiction. UT Health Science Center at San Antonio. March 21-22, 2009 (Oral Presentation). Abstract Book, 2009:A11.
  127. Aliev G, J.C. Shenk, E. Gasimov and Fischbach K. Can mitochondrial antioxidants be novel biological targets of pharmacological treatment in age-associated neurodegenerative mental disorders? In: The WPA International Congress "Treatments in Psychiatry (Florence April 1-4, 2009). World Psychiatry, 2009:8 (Suppl. 1):134.
  128. Schenk, J.C., Castellani, R.J., Moreira, P., Aliev, G., Siedlak, S.L., Harris, P.L.R., Sayre, L., Szweda, P.A., Szweda, L.I., Smith, M.A. and Perry, G. Hydroxynonenal-generated crosslinking fluorophores accumulation in Alzheimer disease reveals a dichotomy of protein turnover. In: Annual Meeting of American Neuropathology Society. J. Neuropathol. Exp. Neurol., 2009, 68(5):A75:571.
  129. Aliev G, Pacheco G., Palaciosa H.H., Perry G., Liu J., Obrenovich M.E., Corredor C., Qasimov E., Ames B.N., Morales L.A. Mitochondrial failure as a primary pathogenetic factor in Alzheimer’s disease which can be diminished by selective mitochondrial antioxidants. In: 9th International Conference - AD/PD 2009 - Prague, Czech Republic, March 11-15, 2009. A-117-0027-01151. Neurodegenerative Diseases, 2009, V. 6; No 3 (v.1-2), Suppl. 1: 1151.
  130. Aliev G Brain Mitochondria as a Primary Target in the Development of Treatment Strategies for Alzheimer Disease. In World Pharmaceutical Congress: Inaugural Targeting Alzheimer’s with Novel Therapeutical Approach: Plenary Distinguish Faculty Lecture (Philadelphia, June 10-11, 2009), Abstract Book, PP.10.
  131. Aliev G., Palacios H.H., Fischbach K., Lipsitt A., Liu J., Xu K., Puchowicz M., Obrenovich M.E., Shenk J.C., Gasimov E., Morales L., Ames B.N. and LaManna J.C. Can mitochondrial antioxidants be novel biological targets of treatment in neurodegenerative disorders? In: ISOTT 2009 - International Society on Oxygen Transport to Tissue: Cleveland, Ohio July 5-9, 2009. Abstract Book, PP. OS-30.
  132. Aliev G, Liu J., Lipsitt A., Fischbach K., Obrenovich M.E., Ames B.N., Qasimov E, LaManna J.C., Morales L. AND Bragin V. Preventing cognitive decline in elderly demented/depressed patients and in ApoE4 mouse as a model of human AD by feeding Acetyl-L-Carnitine and Lipoic Acid. In: International Conference on Alzheimer's Disease; July 11-16, 2009. Vienna, Austria. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2009; Vol. 5, Issue 4, Page P152.
  133. Bragin V., Chemodanova M., Dzhafarova N., Bragin I., Chernyavskyy P. and Aliev G Preservation of cognitive functioning in depressed, demented geriatric patients with cardiovascular risk factors: an ongoing 3 year naturalistic study. In: International Conference on Alzheimer's Disease; July 11-16, 2009. Vienna. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2009; Vol. 5,(4), Page P320.
  134. Bragin V., Chemodanova M., Vaysman A., Bragin I., Chernyavskyy P., Grinayt E., and Aliev G Preservation of learning abilities in people with dementia and depression with different level of cognitive impairment In: International Conference on Alzheimer's Disease; July 11-16, 2009. Vienna, Austria. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2009; Vol. 5, Issue 4, P322.
  135. Aliev G, Daza j., Lipsitt A., Martínez-Agüero M., Palacios H.H., Fischbach K., Obrenovich M.E., LaManna J.C., Bragin V. and Morales L. Silver nanoparticles as alternate strategies for drug delivery to Alzheimer Brain. In: International Conference on Alzheimer's Disease; July 11-16, 2009. Vienna, Austria. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2009; Vol. 5, Issue 4, Page P65.
  136. Aliev G Prevention and treatment of cognitive decline in elderly demented/depressed patients using ApoE4 Tg+ mice as a model of human AD by feeding Acetyl-L-Carnitine and R-a-Lipoic Acid. In: International Conference on Alzheimer's Disease; July 11-16, 2009. Vienna, Austria. HOT TOPIC. Control/Tracking Number: 09-HT-2587-ALZ. P4-321.
  137. Aliev G, Daza j., Lipsitt A., Martínez-Agüero M., Palacios H.H., Fischbach K., Obrenovich M.E., LaManna J.C., Bragin V. and Morales L. Silver nanoparticles as alternate strategies for drug delivery to Alzheimer Brain. In: International Conference on Alzheimer's Disease; July 11-16, 2009. Vienna, Austria. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2009; Vol. 5, Issue 4, Page P324.
  138. Qasimov E., Eyyubova G., Qulieva N. and Aliev G Acute Endotoxeimia as an initiator factor for brain inflammation: Implications for Alzheimer Disease In: International Conference on Alzheimer's Disease; July 11-16, 2009. Vienna, Austria. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2009; Vol. 5, Issue 4, Page P45.
  139. Schenk, J.C., Castellani, R.J., Moreira, P., Aliev, G., Siedlak, S.L., Harris, P.L.R., Sayre, L., Szweda, P.A., Smith, M.A. and Perry, G. Hydroxynonenal-generated crosslinking fluorophores accumulate in Alzheimer disease. In: International Conference on Alzheimer's Disease; July 11-16, 2009. Vienna, Austria. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2009; Vol. 5, Issue 4, Page P315.
  140. Qasimov E., Eyyubova G., Qulieva N. and Aliev G Acute Endotoxeimia as an initiator factor for brain inflammation: Implications for Alzheimer Disease In: International Conference on Alzheimer's Disease; July 11-16, 2009. Vienna, Austria. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2009; Vol. 5, Issue 4, Page P482.
  141. Aliev G, Palacios H.H., Lipsitt A., Fischbach K., Bragin V. Morales L. and Lamb B.T. The development of Alzheimer    disease like pathology in YAC AßPP transgenic mice is associated with the overexpression of Endothelin-1 and Nitric oxide Synthase In: ET-11: APS International Conference on Endothelin. September 9 - 12, 2009, [Marriott Chateau Champlain, Montreal, Canada] (oral presentation). The Physiologist, 2009: Vol. 52, No. 6:Page21 (6.4).
  142. Aliev  G., Manczak M., Grant K.A.  and P. H. Reddy.  Mitochondrial damage as a hallmark for liver and neuronal lesions during chronic ethanol self administration in Cynomolgus monkeys. In: Society for Neuroscience Abstracts 2009,  Chicago, October 17-21, 2009. Control/Tracking Number: 2009-S-6231-SFN. Poster Presentation: P. 344.16.
  143. Aliev G Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion in the Pathogenesis of Tumor Growth: Implication of Nanoparticles for the Drug Delivering. In: Distinguish Faculty Lecture: “Cambridge Healthtech Institute’s Inaugural  The Sciences of Bio-Banking Lectures”. November 16-17, 2009. Crowne Plaza Philadelphia, USA. Abstract Book: Page 15.
  144. Aliev G,  Obrenovich M.E., Liu J., Xu K.,  Puchowicz M., Gasimov E.,  Morales L., Ames B.N.,  LaManna J.C.,  Fischbach K. and Bragin V. Can the mitochondrial antioxidants be novel biological targets in prevention and treatment of cognitive decline in elderly demented and depressed patients? In: 6th International Congress on Vascular Dementia, Barcelona, Spain, November 19-22, 2009 (oral presentation). Abstract Book: Page 33.
  145. Gasimov E., Eyyubova G., Akperov E. and Aliev G Acute endotoxeimia as an initiator factor for brain inflammation: implications for vascular dementia. In: 6th International Congress on Vascular Dementia, Barcelona, Spain, November 19-22, 2009 (oral presentation). Abstract Book: Page 522.
  146. Aliev G, Palacios H.H., Gasimov E., Morales L., Soils A., Bragin V. and Leszek J. Alzheimer Disease: Oxidative Stress Induced Vascular Hypoperfusion and Brain Mitochondrial Failure. New Scents on the Trail? Invited Plenary Lecture. In: The 6th Congress of Polish Association of Psychogeriatry (PTPG), Wroclaw, Poland (December 2-4, 2009). In: Polish J. of Geriatric Psychiatry, 2009, vol. 6, No 4:VI.
  147. Solís-Herrera A., Arias Esparza M. del C., Solís-Arias R.I. , Solís-Arias P.E., Solís-Arias M.P., Palacios H.H. and Aliev G Human photosynthesis and its role in the understanding and treatment of Neurodegenerative diseases: Water splitting capacity of melanin, light and Alzheimer. In: The 6th Congress of Polish Association of Psychogeriatry (PTPG), Wroclaw, Poland (December 2-4, 2009), Polish J. of Geriatric Psychiatry, 2009, vol. 6, No 4:XI.
  148. Gasimov E.K., Quliyeva N.T., Ayyubova G.M., Akbarov E.Ch., Palacios H. H., Pacheco G. J. and Aliev G Structural condition of the perineurial sheath of the sciatic nerve at the experimental edema. In: The 6th Congress of Polish Association of Psychogeriatry (PTPG), Wroclaw, Poland (December 2-4, 2009), Polish J. of Geriatric Psychiatry, 2009, vol. 6, No 4:XI-XII.
  149. Aliev G Oxidative Stress Induced Mitochondria DNA Overproliferation and/or Deletion as a Hallmark in Aged Associated Diseases: Can mitochondrial antioxidants be novel biological targets of treatment in neurodegenerative disorders? Distinguish Faculty Lecture:  “New Leadership of Personalized Medicine” In: BIT's 2nd Annual Congress and Expo of Molecular Diagnostics (CEMD-2009) November 19-21, 2010, Beijing, China. 
  150. Aliev G, Palacios H.H., Gasimov E., Aguirre A., Morales L., Gokhman D., Leszek J., Bragin V. and Solís-Herrera A. Prevention and Treatment of cognitive decline in elderly demented/depressed patients using ApoE4 Tg+ mice as a model of human AD by feeding Acetyl-L-Carnitine, R-a-Lipoic Acid and QUIAPI-1. In: WC 2010, 8th Anti-Aging Medicine World Congress & MediSpa, April, 8 to 10, 2010 Monte-Carlo – MONACO, Faculty Plenary Lecture, EuroMediCom, Abstract Book, 2010, P.119-120.
  151. Aliev G Bragin V. and Burzynski S.R. Can mitochondrial antioxidants be novel biological targets of treatment in cerebrovascular and neurodegenerative disorders? ICAAM & MEDISPA - Middle East International Congress in Aesthetic, Anti-Aging Medicine & Medical Spa - MIDDLE EAST, February 4-9, 2010.
  152. Aliev G, Palacios H.H., Gasimov E., Morales L. and Burzynski S.R. Mitochondrial DNA Overproliferation and Deletion in the Pathogenesis of Tumor Growth: Implication of Nanoparticles for the Drug Delivering. In: 2nd International Conference on Drug Discovery & Therapy (2nd ICDDT 2010) Dubai, UAE, February 1st-4th, 2010.
  153. Aliev G, Palacios H.H., Gasimov E., Morales L. and Burzynski S.R. Alzheimer Disease: Vascular Oxidative Stress and Mitochondrial Failure. New Scents on the Trail? In: 2nd International Conference on Drug Discovery & Therapy (2nd ICDDT 2010) Dubai, UAE, February 1st -4th, 2010.
  154. Aliev G, Palacios H.H., Gasimov E., Aguirre A., Morales L., Gokhman D., Leszek J., Bragin V. and Solís-Herrera A. Targeting Oxidative Stress Induced Cellular Hypoperfusion and Brain Mitochondrial Failure as a Alternate Strategies for the Prevention and Treatment of Cognitive Decline in Elderly Demented/Depressed Patients: New Scents on the Trail? NeuroTalk-2010, Singapore EXPO.
  155. Aliev G, Palacios H.H., Gasimov E., Gokhman D., Leszek J., Obrenovich M.E., Bragin V. and Solís-Herrera A. Oxidative Stress Induced Mitochondrial failure and Brain Hypometabolism as a Primary Target for underlay the pathophysiology of Alzheimer disease and Offer Target for Treatment: Astonishing Effect of Melanin and Mitochondrial Antioxidants. In: 10th International Conference on Alzheimer's Disease; July 10-15, 2010. Honolulu, Hawaii, USA. Alzheimer's & Dementia. July 2010; Vol. 6, Issue 4 (Supplement), P. S591.
  156. Aliev G, Palacios H.H., Gasimov E., Gokhman D., Leszek J., Obrenovich M.E., Bragin V. and Solís-Herrera A. Targeting Oxidative Stress Induced Brain Hypometabolism and Brain Mitochondrial Failure as a New and Effective Strategies for the Prevention and Treatment of Cognitive Decline in Elderly Demented/Depressed Patients and AD: New Scents on the Trail?: In: 10th International Conference on Alzheimer's Disease; July 10-15, 2010. Honolulu, Hawaii, USA. Alzheimer's & Dementia. July 2010; Vol. 6, Issue 4 (Supplement), P. S593.
  157. Gasimov E., Eyyubova G., Obrenovich M.E. and Aliev G Ultrastuctural Characteristics of Cerebral Cortex Astrocytes in Experimental Acute Endotoxeimia. In: 10th International Conference on Alzheimer's Disease; July 10-15, 2010. Honolulu, Hawaii, USA. Alzheimer's & Dementia. July 2010; Vol. 6, Issue 4 (Supplement), P. S753.
  158. Palacios H.H. and Aliev G Mitochondria Antioxidants as Treatment Strategies for Alzheimer disease. In: 10th International Conference on Alzheimer's Disease; July 10-15, 2010. Honolulu, Hawaii, USA. Alzheimer's & Dementia. July 2010; Vol. 6, Issue 4 (Supplement), P. A859.
  159. Shenk J.C., Smith M.A., Castellani R.J., Moreira P., Aliev G, Siedlak S.L., Harris P.L.R., Sayre L., Szweda P.A., Szweda L.I., and Perry G. Lipid Peroxidation Markers are associated with Granulovacuolar Degeneration but not Lipofuscin Formation. In: 10th International Conference on Alzheimer's Disease; July 10-15, 2010. Honolulu, Hawaii, USA. Alzheimer's & Dementia. July 2010; Vol. 6, Issue 4 (Supplement), P. S230.
  160. Aliev G, Palacios H.H., Gasimov E., Gokhman D., Leszek J., Obrenovich M.E., Bragin V. and Solís-Herrera A. Oxidative Stress-induced Mitochondrial Failure, Cellular Hypoperfusion and Brain Hypometabolism Underlay the Pathophysiology of Alzheimer Disease and Offer New and Successful Targets for Treatment. In: XII Argentinean Congress on Neuropsychiatry and XIII meeting on Alzheimer’s Disease Meeting, Buenos Aires, Argentina, September 1-3, 2010V. In: Revista de Neuropsiquiatria y Neurociencia Cognitiva, 2010, V.9, P.13.
  161. Aliev G Oxidative Stress-induced Mitochondrial DNA Overproliferation and Deletion, Cellular Hypoperfusion and Brain Hypometabolism Underlay the Pathophysiology of Cerebrovascular and Alzheimer Disease: Offer New and Successful Targets for the Drug Delivering and Treatment. In: 80th Anniversary International Conference of Azerbaijan Medical University, Baku, October 4-5, 2010. Abstract Book, Baku, 2010, P.P. 486-488.
  162. Aliev G, Palacios H.H., Leszek J., Obrenovich M.E., Bragin V. and Solís-Herrera A. Oxidative Stress-Induced Brain Hypometabolism Underlies The Pathophysiology Of Alzheimer Disease And Offers New And Successful Targets For Treatment: Astonishing Therapeutics Effects From A Combination Of A Melanin Precursor (QIAPI-1) And Selective Mitochondrial Antioxidants (ALCAR+LA): New Scent On The Trail? In: Clinical Trials for AD (CtaD10), Toulouse (France) November 3-5, 2010. Abstract book. 10. (Oral Presentation).
  163. Aliev G Oxidative Stress-induced Mitochondrial DNA Overproliferation and Deletion, Cellular Hypoperfusion and Brain Hypometabolism In the Context of Cerebrovascular and Alzheimer Disease : Offer New and Successful Targets for the Drug Delivering and Treatment. In: The 7th Congress of Polish Association of Psychogeriatry (PTPG), Wroclaw, Poland (December 2-3, 2010). Polish Journal of Geriatric Psychiatry, 2010, 7(4); 141-144.
  164. Aliev G, Palacios H.H., Bhushan B.Y., Gasiorowski K., Gokhman D., Shadlinski V.B., Bragin V. and Leszek J. Oxidative Stress Induced Mitochondrial DNA Overproliferation and Deletion, Cellular Hypoperfusion and Hypometabolism in the Context of Aging and Aged-Associated Diseases: Offer New and Successful Targets for Drug Delivery, Prevention and Treatment. AMWC 2011 - Monaco 9th ANTI-AGING MEDICINE WORLD CONGRESS Global Anti-Ageing Management, March 24-25-26, 2011 Monte-Carlo, MONACO, Grimaldi Forum , Lecture. Abstract Book, 2011, pp, 118-120.
  165. Aliev G Oxidative Stress-induced Mitochondrial Failure, Cellular Hypoperfusion and Brain Hypometabolism Underlay the Pathophysiology of Alzheimer Disease: Mitochondrial Antioxidants and Metabolites as a New and Successful Targets for Treatment. In: PepCon 2011, Beijing, China (Accepted: Oral presentation).
  166. Aliev G Oxidative Stress-induced Mitochondrial DNA Overproliferation and Deletion, Cellular Hypoperfusion and Brain Hypometabolism in the Context of Alzheimer Disease: Past, Present and Future. In: International Conference on Alzheimer’s Diseases, 2011 (July 16-21, 2011, Paris, France) . Accepted for Oral presentation (Proposal ID: 12878).
  167. Aliev G, Palacios H.H., Shadlinski V.B., Gokhman D., Gasirovwski K. and Leszek J. Silver nanoparticles as alternate and successful strategies for drug delivery to Alzheimer Brain. In: The 15th Congress of the European Federation of Neurological Societies - EFNS 2011 (Budapest, Hungary, September 10-13, 2011). Accepted for Poster presentation (Reference # A-369-0001-01901).
  168. Aliev G Oxidative Stress-induced Mitochondrial DNA Overproliferation and Deletion, Cellular Hypoperfusion and Brain Hypometabolism In the Context of Dementia: Offer New and Successful Targets for Drug Delivery and Treatment. Plenary Lecture. In: 7th International Congress on Vascular Dementia, Riga Latvia. October 20-23, 2011 (in press).
  169. Aliev G and Bragin V. Aged Associated Mitochondrial DNA Overproliferation and Deletion, Cellular Hypoperfusion and Hypometabolism in the Context of Cardiovascular and Neurological Disorders: Successful Treatment Strategies by Using Mitochondrial Selective Antioxidants and Nutrients In:7th European Masters in Aesthetic and Anti-Aging Medicine (EMAA), September 30th to October 1st, 2011. Paris, France (Plenary Lecture, Submitted).
  170. Aliev G and Bragin V. Aged Associated Mitochondrial DNA Overproliferation and Deletion, Cellular Hypoperfusion and Hypometabolism in the Context of Cardiovascular and Neurological Disorders which Can Be Used as a Alternate and Successful Drug Treatment Strategy: Past, Present and Future. In: 13th Argentinean Congress on Neuropsychiatry, "Biomarkers and Resilience in Neuropsychiatry ”, 9th Latin-American Congress on Neuropsychiatry and 14th Argentinean Meeting on Alzheimer’s Disease, Buenos Aires, Argentina. August 24- 26, 2011 (Plenary Lecture, Submitted).